fluorodeoxyglucose f18 has been researched along with Stomach Neoplasms in 378 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.26) | 18.7374 |
1990's | 9 (2.38) | 18.2507 |
2000's | 100 (26.46) | 29.6817 |
2010's | 203 (53.70) | 24.3611 |
2020's | 65 (17.20) | 2.80 |
Authors | Studies |
---|---|
Belt, EJT; Brenkman, HJF; Daams, F; de Steur, WO; Eker, HH; Frederix, GWJ; Gertsen, EC; Gisbertz, SS; Haj Mohammad, N; Hartgrink, HH; Heisterkamp, J; Hol, L; Hulsewe, KWE; Kouwenhoven, EA; Lagarde, SM; Luyer, MDP; Nieuwenhuijzen, GAP; Pierie, JP; Ruurda, JP; Siersema, PD; Spillenaar Bilgen, EJ; Stoot, JHMB; Thijssen, AY; van Berge Henegouwen, MI; van den Berg, JW; van der Meulen, MP; van der Peet, DL; van Det, MJ; van Duijvendijk, P; van Etten, B; van Grieken, NCT; van Hillegersberg, R; van Laarhoven, HWM; van Lanschot, JJB; van Sandick, JW; Vegt, E; Wassenaar, E; Wessels, FJ; Wevers, KP; Wijnhoven, BPL | 1 |
Cheng, Z; Kou, Y; Yao, Z | 1 |
Murakami, Y; Murata, K; Murata, S; Nagatani, Y; Nitta, N; Seko-Nitta, A; Takemura, S; Watanabe, Y | 1 |
Clements, HA; Patil, P; Petty, R; Ramkumar, PG; Walsh, S | 1 |
Du, B; Hao, W; Li, X; Li, Y | 1 |
Arslan, E; Beyhan, E; Çermik, TF; Ergül, N; Erol Fenercioğlu, Ö | 1 |
Alacacioğlu, A; Avci, A; Cengiz, F; Eren Kalender, M; Güç, ZG; Turgut, B | 1 |
Du, B; Jing, S; Li, X; Li, Y; Wang, S | 1 |
Jia, X; Pan, L; Zhang, Y; Zhao, X; Zhou, L; Zhou, X | 1 |
Gökçek, A; Ozmen, O; Tatci, E | 1 |
Dong, K; Huang, Q; Qin, C; Wang, S; Wen, G | 1 |
Allen, M; Anconina, R; Chen, EX; Darling, GE; Elimova, E; Jang, RW; Liu, ZA; Metser, U; Ortega, C; Swallow, CJ; Taylor, K; Veit-Haibach, P; Wong, R; Yeung, J | 1 |
Dong, A; Ji, X | 1 |
Foley, KG; Goh, V; Withey, SJ | 1 |
Hasegawa, H; Kakeji, Y; Kanaji, S; Matsuda, T; Oshikiri, T; Suzuki, S; Urakawa, N; Yamada, K; Yamamoto, M; Yamashita, K | 1 |
Arslan, E; Beyhan, E; Çermik, TF; Erol Fenercioğlu, Ö; Tatar, G | 1 |
Bradley, KM; Coles, B; Coomer, W; Foley, KG | 1 |
Ma, D; Shao, X; Wu, C; Wu, J; Zhang, Y | 1 |
Akdemir, ÜÖ; Atay, LÖ; Aydos, U; Dursun, A; Gülbahar Ateş, S; Üner, A; Yüksel, O | 1 |
Beyhan, E; Çermik, TF; Ergül, N; Erol Fenercioğlu, Ö; Yarikkaya, E | 1 |
Bai, J; Guo, H; Li, J; Li, S; Wang, H; You, Y; Zhang, C; Zhang, H; Zheng, P | 1 |
Aoba, T; Arimoto, A; Fukaya, M; Hiramatsu, K; Kato, T; Kawashima, K; Yamaguchi, T | 1 |
Capanu, M; Chou, JF; Janjigian, YY; Lewis, JS; Lumish, MA; Lyashchenko, SK; Maron, SB; O'Donoghue, JA; Pandit-Taskar, N; Paroder, V; Philemond, S; Schöder, H | 1 |
Giesel, FL; Watabe, T | 1 |
Cui, XM; Du, T; Hu, RH; Jiang, JJ; Jiang, XH; Wang, HY; Zhang, S; Zhao, J; Zhong, L | 1 |
Chen, Y; Deng, J; Li, K; Liu, H; Xiang, F | 1 |
Abe, K; Cardinale, J; Doki, Y; Eguchi, H; Giesel, FL; Inohara, H; Kamiya, T; Kato, H; Kimura, T; Kobayashi, S; Kurokawa, Y; Miyake, T; Mori, Y; Naka, S; Shimazu, K; Shintani, Y; Tatsumi, M; Watabe, T | 1 |
Abbey, L; Abdelghany, TM; Abdellatif, MH; Abdelmohsen, UR; Abduljaleel Alzawar, NS; Abid, MF; Abu Kasim, AFB; Abu Saad, H; Adolpho, LF; Agostini, F; Agrizii, AP; Ahmed, S; Akce, M; Åkesson, D; Al-Awaadh, AM; Al-Mutar, DMK; Al-Odayni, AB; Al-Rajhi, AMH; Alaaeldin, R; Alam, M; Alam, MM; Alanazi, MA; Alattar, H; Alawlaqi, MM; Aldebis, HK; Algehainy, NA; Almeida, AA; Aloisi, F; Alrahlah, A; Alsenani, F; Alshabib, A; Altemani, FH; Althagafi, A; Amari, A; Andronesi, AG; Antonyuk, M; Arantes, TD; Araújo, R; Arrotti, S; Asakura, T; Asib, N; Atlaskin, AA; Aung, MS; Axiaq, A; Azekawa, S; Bacon, S; Bagalagel, A; Balbinot, GS; Barnet, LS; Baroyi, SAHM; Barreto, F; Barth, Y; Barysheva, AV; Bassa, E; Basu, R; Basu, S; Bates, C; Bautista, LS; Beitl, K; Beloti, MM; Benatti, G; Benavent-Celma, C; Bentaher, A; Bergsland, N; Bernardino, AF; Bernhardt, A; Bhandari, RK; Bhaskaran, K; Bhate, K; Bhattacharjee, A; Bian, X; Bien, EM; Birch, M; Bishara, K; Biswas, JP; Bleha, R; Bocale, R; Bona, S; Boriani, G; Bouyssi, A; Bradley, D; Bravo-Sánchez, MG; Bressan, GC; Brik, A; Brizuela, A; Brockbank, KGM; Buchner, F; Bunc, M; Buscombe, JR; Butler, AJ; Buzaleh, AM; Buzin, MI; Cabrera-Capetillo, CA; Calvo, AM; Camerota, A; Campagna, G; Campisi, M; Cano, K; Cao, HST; Cardellini, S; Carvalho, AP; Carvalho, BCR; Castillo-Baltazar, OS; Cataldo, P; Chai, P; Chakraborty, S; Chalo, DM; Chan, MY; Chander, S; Changbunjong, T; Chappuis, CJF; Chee, RCH; Chen, C; Chen, CJ; Chen, E; Chen, M; Chen, X; Chen, Y; Cheng, HT; Cheng, MC; Cheow, HK; Chi, Y; Chirikova, NK; Chiu, SH; Cho, G; Cho, HR; Cho, S; Cho, SJ; Choe, A; Choe, YH; Chun, BS; Chun, Z; Cinque, A; Ciopec, M; Cladas, Y; Cleary, SP; Clermont, O; Cléroux, M; Cockburn, J; Collares, FM; Colombini-Ishikiriama, BL; Conn, BN; Cortina, JL; Cox, DRA; Crini, G; Croker, R; Cursaru, DL; Curtis, HJ; da Silva, KJG; Dalla Costa, T; Davy, S; de Araújo, BV; de Cassia Ribeiro Gonçalves, R; de Gaetano, F; de Gregorio, C; de Oliveira, MG; De Vera, MAT; de Vos, M; de-la-Fuente, I; Dell'Oca, I; Delles, M; Déméautis, T; Dempster, M; Deng, YH; Denisenko, Y; Descombes, C; Desideri, G; Devarbhavi, H; Devouassoux, G; Di Bella, G; Di Marco, F; Diao, Y; Dias, BB; Dilgin, Y; Dimopoulou, I; Dionísio, TJ; Dobrovic, A; Dokin, ES; Dolby, T; Dong, X; Dong, Y; Dou, SX; Douglas, IJ; Dousset, S; Du, Z; Duan, M; Duan, SB; Duke-Williams, O; Duteanu, N; Dutertre, S; Dutta, S; Dwyer, MG; Ebenbauer, J; Eggo, RM; El-Mordy, FMA; Elbhnsawi, NA; Elrehany, MA; Elshewemi, SS; Elwakil, BH; Emadzadeh, D; Eraso, E; Ermolenko, E; Erten, K; Ettorre, E; Evans, D; Evans, SJ; Faheem, M; Fallanza, M; Faramarzi, M; Faria, FAC; Faro, DC; Fatma, YS; Fazil, S; Feng, Y; Ferguson, J; Fernandes, MH; Fernández-Domínguez, M; Ferrari, LAL; Ferraz, EP; Ferreira, LC; Ferri, C; Fikry, M; Floris, M; Forbes, H; Fotouh, B; Franke, K; Freitas, AC; Freitas, GP; Frieboes, HB; Fu, B; Fu, Y; Fukina, DG; Fukuda, DH; Fukunaga, K; Fulham, GJ; Furlan, L; Furtado Mesa, M; Furtunescu, FL; Gabbieri, D; Ganash, M; Gebers, JC; Gehman, V; Ghaedi, A; Ghazali, NSM; Ghebrekristos, Y; Gil, J; Gilbert, NM; Gimenes, R; Giordano, L; Glehen, O; Godeau, C; Goh, SK; Goldacre, B; Gomes, AM; Gomes, MPO; Gomes, PS; Gomes, RMODS; Gómez-Coma, L; Grenho, L; Gu, Q; Gu, T; Gu, YC; Guiducci, V; Guillemin, JP; Guo, W; Guo, YW; Gur, E; Guridi, A; Guzmán-López, A; Gvozdenko, T; H Elmaidomy, A; Hagar, M; Haider, S; Han, JM; Hanratty, J; Hans, R; Haque, N; Harharah, HN; Harharah, RH; Harper, S; Hasegawa, N; Hassanin, AH; Hastuti, YP; Hatem, AE; He, R; He, Y; Heinemann, C; Heinmaa, I; Heinzl, F; Helfer, VE; Hester, F; Hickman, G; Hill, MA; Hill, WG; Hintze, V; Ho, JSY; Ho, LY; Hoang, T; Holzer, I; Houbraken, J; Hsu, CN; Hu, J; Hu, X; Hu, Y; Hua, T; Huang, Z; Hulme, WJ; Hunter, A; Ianăşi, C; Ibañez, R; Iezzi, R; Iliuță, L; Im, YM; Imran, M; Inglesby, P; Inguimbert, N; Iqbal, A; Izawa, N; Jahaj, E; Jain, S; Jakimovski, D; Jalal, MM; Jaroszuk-Ściseł, J; Jasim, DJ; Jauregizar, N; Javle, MM; Jędryczka, M; Ji, H; Jiang, Y; Jin, J; Johnson, NT; Joshi, S; Jullok, N; Kachapulula, PW; Kaczmarek, J; Kaczmarek-Szczepańska, B; Kadota, K; Kaji, M; Kakeji, Y; Kakizoe, S; Kakudidi, E; Kalitukha, L; Kamata, H; Kang, YJ; Kapinos, AA; Karakaya, S; Kashchenko, NI; Kasyanov, S; Kataky, R; Katati, B; Kato, G; Katsina, AU; Kaya, A; Kaya, H; Kazarina, OV; Ke, Y; Keenan, C; Keilson, JM; Keshavan, A; Keskinidou, C; Khalifa, MA; Khan, R; Khan, S; Kim, D; Kim, K; Kim, MS; Kim, SM; Kim, WH; Kim, Y; Kim, YJ; Kishimura, H; Kitagawa, RR; Klemenkova, ZS; Kloss, F; Kobayashi, N; Kohlhoff, M; Kong, WKF; Konsek, H; Kornaros, M; Kotanidou, A; Kovacs, S; Kraska, J; Kruppke, B; Kumagai, Y; Kumar, S; Kumari, R; Kuruva, V; Kuster, RM; Kusumoto, T; Kutyła, M; Kwon, JH; Kwon, SH; Kwong, KY; Kyser, AJ; Lackner, M; Lass-Flörl, C; Lauri, C; Lavandera, JV; Lee, BH; Lee, ECY; Lee, HJ; Lee, J; Lee, PS; Lee, S; Lee, SE; Lee, SY; Lefort, F; Leite, JPV; Leo, G; Leonard, R; Leow, AST; Lepori, N; Leyden, K; Leys, L; Ležaić, L; Li, D; Li, H; Li, J; Li, S; Li, TYW; Li, X; Li, XH; Li, Y; Li, Z; Li, ZH; Liao, S; Liaqat, K; Lim, H; Lin, BS; Lin, MY; Lin, NH; Lin, X; Lin, Y; Liu, C; Liu, H; Liu, HK; Liu, HX; Liu, P; Liu, R; Liu, T; Liu, X; Liu, Y; Lock, GA; Lokaj, G; Lopes, HB; Losi, V; Lotsios, NS; Low, KE; Lu, Z; Luhana, S; Luo, X; Luo, XQ; Lutz, MB; Lysova, AA; Lyssenko, KA; Macit, M; MacIver, B; MacKenna, B; Magalhães, GAP; Magnavacchi, P; Mahadevan, J; Mahboubi, A; Maher, SA; Mahipal, A; Mahmoud, MY; Maithel, SK; Makhtar, MMZ; Makurat-Kasprolewicz, B; Malysheva, YB; Mansourizadeh, A; Marek, EJ; Maresca-Fichter, H; Martin, JT; Maslov, AA; Mastora, Z; Mastroiacovo, D; Mastropetros, SG; Matei, D; Mathur, R; Matos, AO; Matsuda, Y; Maurya, SK; Mayor, Á; Mayrhofer, D; Mazzuco, AC; McCaffrey, J; McClure, T; McDonald, HI; Mchunu, NP; McLaggan, D; Mehrkar, A; Meilik, B; Melito, VA; Mellem, J; Mengozzi, A; Menotti, J; Mesquita, V; Miao, Z; Mihai, S; Miller, S; Minassian, C; Mirabile, A; Mitra, S; Mladin, G; Mo, Z; Moawad, H; Mohamed, EM; Mohammed, TJ; Mohanlall, V; Mohyeldin, RH; Moldovan, H; Monneret, G; Monopoli, DE; Monte, IP; Monteiro, JRB; Morgante, V; Mori, M; Morin-Crini, N; Morita, A; Morton, CE; Mrak, M; Muhammed, AP; Mulick, A; Muralidharan, V; Murthy, P; Muselli, M; Mustafa, S; Mysore Visweswariah, A; Nagao, G; Naicker, S; Nakagawara, K; Namgoong, B; Namkoong, H; Namukobe, J; Nasir, AA; Nasreen, SA; Natarajan, P; Nchiozem-Ngnitedem, VA; Necozione, S; Negrea, A; Negrea, P; Ngubane, S; Nguyen, TT; Nicke, A; Nightingale, E; Nistor, CL; Nitsch, D; Njapau, H; Noman, M; Novgorodtseva, T; Nowak, A; O'Connor, SR; Ofoe, R; Oh, K; Oh, TH; Oki, E; Olama, ZA; Olennikov, DN; Oliveira, GM; Omar, D; Ong, SJ; Orfanos, SE; Origa-Oryem, H; Orita, H; Ortiz, I; Ota, M; Ott, J; Otvagina, KV; Pacheco, N; Pacheco, RR; Padmanabhan, D; Pagan, JD; Pagnotta, PA; Palangi, V; Palanisamy, G; Palanisamy, K; Palanisamy, S; Pan, SG; Panaitescu, E; Pang, X; Panoutsakopoulos, V; Parera, VE; Park, JI; Park, JS; Park, SW; Park, Y; Park, YS; Parkash, O; Parry, J; Parry, JP; Paul, SK; Pavšič, N; Pałubicka, A; Persat, F; Petriz-Prieto, MA; Petukhov, AN; Pham, T; Pillay, S; Poh, KK; Ponomarev, II; Pontons-Melo, JC; Posa, A; Powell, E; Priya, AK; Punekar, R; Puppin Rontani, RM; Purushottam, M; Pusphanathan, K; Qi, JY; Qin, J; Qin, Z; Qiu, B; Qiu, X; Quattrini, G; Quindós, G; Qureshi, F; Rabbany, MA; Rac-Albu, M; Rac-Albu, ME; Rădulescu, BC; Rafatullah, M; Rajab, TK; Rajna, S; Ramanathan, M; Rao, D; Raviglione, D; Razorenov, DY; Redd, MJ; Rehman, W; Reig, M; Rentsch, CT; Ribeiro, LMS; Robles, D; Rocchi, S; Rocha, FG; Rodrigues, C; Rodrigues, LA; Rodrigues, RP; Roh, GH; Ronowska, A; Root, A; Rosa, AL; Rossi, R; Roy, S; Roy, VC; Rupji, M; Saber, EA; Sadarat, F; Saed, Y; Saeed, WS; Saeki, H; Saha, B; Saiwichai, T; Sakowicz-Burkiewicz, M; Sampedro, T; Sands, K; Santos, CF; Sari, M; Sathi, FA; Sauro, S; Sazanova, TS; Scafa-Udriște, A; Schoustra, SE; Schultze, A; Seo, DJ; Sevillano, E; Sezmis, G; Sgura, FA; Shah, NNAK; Shani, N; Shankarappa, B; Sharkey, LM; Sharma, VK; Sharp, C; Shehata, N; Shelton, N; Shieh, PB; Shimokawa, M; Shin, J; Shin, SH; Shin, YN; Shin, YR; Shipilova, A; Shoparwe, NF; Shukor, H; Sia, CH; Siddiqui, MH; Siddiqui, MR; Siena, V; Signore, A; Silwane, B; Siqueira-Sandrin, VS; Siregar, A; Sirignano, P; Sit, NW; Skidmore, S; Skupov, KM; Smeeth, L; Smoczer, C; Smolyanskiy, E; Sohn, H; Solodeev, I; Solovyev, A; Şomoghi, R; Song, F; Song, H; Song, Z; Souf, YM; Sousa, SC; Souza, MT; Steinbach-Rankins, JM; Stockton, J; Stout, JR; Su, K; Su, MZ; Suarez-Lopez, YA; Sukkurd, R; Sultanov, R; Sun, Y; Sun, Z; Supernak, M; Supriyono, E; Suroshe, SS; Suvorov, SS; Svera M Ianăşi, P; Switchenko, JM; Syarif, NY; Synytsya, A; Taherzadeh, MJ; Tain, YL; Tamburino, C; Tammam, OY; Tan, BYQ; Tan, H; Tan, S; Tanaka, H; Tang, R; Tang, X; Tang, Z; Taurino, M; Tazare, J; Teresi, L; Testro, A; Thanasoponkul, W; Thangarasu, S; Thavaselvam, D; Theodoro, RC; Theron, G; Thomas, RH; Thomson, JJ; Tian, X; Tian, Y; Tomaszewski, CA; Tomlinson, LA; Torres, CMME; Tóth, M; Trecourt, A; Trevisani, F; Trimarchi, G; Tristán, C; Truong, VK; Tsigkou, K; Tsutsumi, S; Ubukata, Y; Uehara, H; Uwamino, Y; Vahedi-Shahandashti, R; Valberg, SJ; Valderrama, C; Valdovinos-García, EM; Valsecchi, D; van Diepeningen, AD; van West, P; Vargas-Osuna, E; Vassall, M; Vassilaki, N; Vassiliou, AG; Vecino, X; Velez-Irizarry, D; Venkatesh, YN; Vignali, L; Virdis, A; Viswanath, B; Voisin, AS; Volkova, YA; Vorotyntsev, AV; Vorotyntsev, IV; Vtyurina, ES; Vu, DH; Waldridge, B; Walker, AJ; Wallon, M; Wang, B; Wang, G; Wang, H; Wang, J; Wang, LJ; Wang, S; Wang, T; Wang, X; Wang, Z; Warren, RM; Warren-Gash, C; Wei, SH; Weinstock-Guttman, B; Wekwejt, M; Wessjohann, LA; Wiesmann, HP; Williams, ZJ; Williamson, EJ; Wilson, M; Wing, K; Wong, AY; Wong, BKL; Woodward, S; Wozniak, KL; Wu, C; Wu, K; Wu, S; Wu, Y; Xiang, D; Xie, H; Xiong, X; Xu, C; Xu, H; Xu, J; Xu, WH; Xu, Y; Xun, T; Yamaguchi, S; Yan, P; Yan, W; Yan, Z; Yang, B; Yang, F; Yang, L; Yao, XB; Yasui, H; Yenesew, A; Yeo, LLL; Yeo, TC; Yi, S; Yin, F; Yip, JWL; Yoon, SH; Yoon, SJ; Yoshida, M; Yoshizumi, T; Young, LA; Yu, C; Yu, DD; Yu, F; Yu, H; Yu, JD; Yu, NJ; Yu, X; Yuan, Y; Yurenko, A; Yusof, YA; Zahedipoor, A; Zahran, EM; Zainuddin, NI; Zanatta, AC; Zanotto, ED; Zanozin, ID; Zavascki, AP; Zenke, M; Zhang, F; Zhang, G; Zhang, H; Zhang, J; Zhang, L; Zhang, MX; Zhang, NY; Zhang, Q; Zhang, W; Zhang, X; Zhang, XM; Zhao, F; Zhao, Q; Zhao, R; Zhao, Y; Zheng, J; Zheng, S; Zhou, L; Zhou, X; Zhu, H; Zivadinov, R; Žižek, D; Zuccoli, JR; Zwaan, BJ | 1 |
Albano, D; Annunziata, S; Bertagna, F; Dondi, F; Fenocchio, E; Garrou, F; Pellegrino, L; Racca, M; Rizzo, A; Treglia, G | 1 |
Murakami, T; Nogami, M; Sugiyama, N; Zeng, F | 1 |
Huang, L; Liu, J; Shi, A; Su, Y; Wang, J; Xie, L; Yu, X; Zha, J | 1 |
M V, M; Manda, D; Shukla, V; Suresh, A | 1 |
Iwata, J; Matsumoto, M; Murokawa, T; Okabayashi, T; Ozaki, K; Sakamoto, S; Sui, K; Tabuchi, M; Yoshida, H | 1 |
Cho, YS; Chung, IK; Lee, JW; Lee, MS; Lee, SM; Son, MW | 2 |
Han, JK; Kim, SH; Yoo, J | 1 |
Guo, X; Yang, M; Yang, Z; Zhou, N; Zhu, H | 1 |
Baiocchi, G; Bencivenga, M; Colciago, E; Framarini, M; Fumagalli Romario, U; Giacopuzzi, S; Graziosi, L; Marino, E; Moretti, A; Morgagni, P; Mura, G; Rossi, V; Saragoni, L; Tringali, D; Verlato, G | 1 |
Kawajiri, H; Miyashita, M; Takada, K | 1 |
Akashi, H; Imamura, T; Ishibashi, Y; Kodama, M; Matsumura, M; Morimitsu, Y; Muroya, D; Nishimura, T; Sato, H; Shimokobe, T; So, H; Taketani, S; Taniwaki, S; Wada, Y; Yoshimoto, Y | 1 |
Bignotto, A; Cecchin, D; Evangelista, L; Ravelli, I; Zucchetta, P | 1 |
Kimura, K; Manabe, O; Tateishi, U; Toshiaki, I; Tsuchiya, J; Yokoyama, K | 1 |
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Borggreve, AS; Brenkman, HJF; Gertsen, EC; Ruurda, JP; Siersema, PD; van Hillegersberg, R; Vegt, E; Verhoeven, RHA | 1 |
Abraham, V; Samarasam, I; Surendran, S; Zechariah, P | 1 |
Can, C; Güzel, Y; Komek, H; Tasdemir, B | 1 |
Farahmandfar, F; Moradian, S; Sadeghi, R; Shahlaei, S; Shakeri, S | 1 |
Guo, H; Li, W; Meng, Z; Zhou, H | 1 |
Chen, H; Guo, W | 1 |
Chicco, A; Cong, E; Ho Shon, I; Lee, MT; Lin, M; Lin, P; Oar, AJ; Yap, J | 1 |
González, E; Martí, A; Morón, S; Rojas, J | 1 |
Asopa, RV; Loharkar, S; Malhotra, G | 1 |
Ge, Y; He, J; Ji, CF; Liu, S; Sun, YW; Wang, H; Zhou, ZY | 1 |
Cheon, GJ; Kang, SY; Kim, TY; Oh, DY; Yoo, SH; Yoon, J | 1 |
Ahmad, W; Asghar, N; Bashir, H; Zafar, T | 1 |
Fu, L; Li, L; Wang, L; Zheng, Y | 1 |
Khan, KS; Mahmud, S; Mathias, N; Reed-Embleton, H | 1 |
Kizawa, K; Kosone, T; Marubashi, K; Takagi, H; Takakusagi, S; Tojima, H; Yokoyama, Y | 1 |
Bjerring, OS; Fristrup, CW; Hess, S; Lundell, L; Mortensen, MB; Petersen, H | 1 |
Lin, R; Lin, Z; Miao, W; Yao, S; Zhang, J | 1 |
Arigami, T; Daisaki, H; Kitajima, K; Miwa, H; Nakajo, M; Nakamura, A; Ohtsuka, T; Toriihara, A; Yoshiura, T | 1 |
Choi, JY; Hyun, SH; Kim, SJ; Kim, WS; Lee, JH; Lee, KH; Min, BH; Moon, SH; Park, YJ | 1 |
Cao, J; Chen, Y; Huang, Y; Liu, H; Peng, D | 1 |
Bae, SW; Berlth, F; Cheon, GJ; Choi, H; Choi, JH; Jeong, KY; Kang, KW; Kim, JI; Kong, SH; Lee, C; Lee, HJ; Park, DJ; Park, JH; Park, SH; Suh, YS; Yang, HK; Youn, H | 1 |
Salmanoglu, E | 1 |
Benli, F; Güler, M; Ozmen, O; Tatci, E; Uslu Biner, I | 1 |
Chen, X; Gao, P; Ma, B; Song, Y; Sun, J; Wang, Z; Wu, Z; Zhao, J | 1 |
Bai, L; Duan, XY; Gao, JG; Guo, CH; Guo, YM; Li, M; Shen, C; Zhao, Y | 1 |
Broski, SM; Goenka, AH; Johnson, GB | 1 |
Farahani, ZA; Hess, S; Tind, S; Vestergaard, S | 1 |
Bang, YJ; Cheon, GJ; Ha, S; Kim, TY; Kim, WH; Kwon, HW; Oh, DY; Park, S | 1 |
An, YS; Han, SU; Lee, D; Lee, JH; Lee, KM; Lee, SJ; Park, S; Yoon, JK | 1 |
Kan, Y; Wang, W; Yang, J; Yuan, L | 1 |
Bulut, N; Yılmaz, B | 1 |
Dwary, AD; Khan, EM; Sharma, P | 1 |
Marcus, C; Subramaniam, RM | 1 |
Alessi, A; Battiston, C; Berenato, R; Caporale, M; Coppa, J; Cotsoglou, C; de Braud, F; Delconte, G; Di Bartolomeo, M; Fucà, G; Greco, G; Infante, G; Lazzati, S; Mazzaferro, V; Mennitto, A; Morano, F; Niger, M; Padovano, B; Pellegrinelli, A; Pietrantonio, F | 1 |
Ou, X; Shen, Y; Su, M; Yao, Y | 1 |
Cola, B; Cuicchi, D; De Raffele, E; Lecce, F; Mirarchi, M | 1 |
Guo, XY; Lu, YF; Wang, TA; Xian, SL; Zhang, XD | 1 |
Hu, P; Jin, C; Ma, B; Pan, Q; Wei, Z; Zhang, BN | 1 |
Doi, H; Hirata, K; Kaida, H; Kitajima, K; Minamimoto, R; Nakajo, M; Sofue, K; Tamaki, Y; Tsurusaki, M; Ueno, Y; Yamakado, K | 1 |
Niu, R; Qiu, C; Shao, XL; Wang, JF; Wang, YT; Zhang, DC | 1 |
Buxó, E; Colletti, PM; Fernández-Esparrach, G; Fuster, D; Ginés, A; Mayoral, M; Ortín, J; Pagès, M; Perlaza, P; Rubello, D; Ruiz, C; Sánchez, N | 1 |
Castaldi, P; Inzani, F; Lorusso, M; Menghi, R; Rindi, G; Rufini, V; Schinzari, G | 1 |
Arita, T; Fujiwara, H; Ikoma, H; Komatsu, S; Konishi, H; Kosuga, T; Kubota, T; Kudou, M; Kuriu, Y; Morimura, R; Murayama, Y; Nakanishi, M; Okamoto, K; Otsuji, E; Shiozaki, A; Shoda, K | 1 |
Kim, BS; Kim, Y; Lee, KE; Moon, CM; Yoo, J; Yoon, HJ | 1 |
Bauerfeind, P; Eshmuminov, D; Lehmann, K; Rordorf, T; Samaras, P; Schneider, PM; Veit-Haibach, P; Vetter, D; Weber, A | 1 |
Li, F; Li, J; Luo, Y; Pan, Q; Zhang, S | 1 |
Bang, HY; Chung, HW; Kim, JH; Lee, EJ; Lee, SY; Park, HS; Shim, CS; So, Y; Sung, IK | 1 |
Chen, Y; Shao, F; Zhang, S | 1 |
Chen, H; Hu, Y; Huang, W; Jiang, Y; Li, G; Li, T; Liu, W; Lu, L; Lv, W; Ma, J; Sun, Z; Wang, Q; Xi, S; Yu, J; Yuan, Q; Zhao, L | 1 |
Antonowicz, S; Bradley, KM; El Kafsi, J; Findlay, JM; Gillies, RS; Maynard, ND; Middleton, MR; Segaran, A; Zhang, A | 1 |
Janjigian, YY; Mondaca, S | 1 |
Ålgars, A; Kemppainen, J; Ristamäki, R; Salminen, P; Sundström, J; Vihervaara, H | 1 |
Adachi, K; Ebi, M; Funaki, Y; Hijikata, Y; Inoue, S; Izawa, S; Kasugai, K; Kurahashi, S; Ochiai, T; Ogasawara, N; Onishi, K; Saito, T; Sasaki, M; Sugiyama, T; Tamura, Y; Yamaguchi, Y; Yamamoto, K; Yoshimine, T | 1 |
Kapoor, R; Kumar, R; Mittal, BR; Parihar, AS; Singh, H; Vadi, SK | 1 |
Fan, Q; Su, M | 1 |
An, YS; Byun, C; Han, SU; Hur, H; Jo, KS; Lee, D; Lee, KM; Lee, SJ; Lim, SK; Yoon, JK | 1 |
Kim, HH; Kim, SE; Kim, YH; Lee, HY; Lee, KH; Lee, SJ; Lee, WW; Park, DJ; So, Y; Yoon, HJ | 1 |
Guo, Q; Liu, C; Ma, Q; Xin, J; Xu, W; Yu, S; Zhai, W; Zhao, Z | 1 |
Carbonetti, G; Carlin, SD; Chiosis, G; de Stanchina, E; Divilov, V; Gomes-DaGama, EM; Holland, JP; Janjigian, YY; Lewis, JS; Viola-Villegas, N | 1 |
Guo, W; Hu, S; Li, J; Wang, C; Yao, Z; Zhang, Y; Zhou, M | 1 |
Ciarallo, A; Derbekyan, V; Hickeson, M; Lisbona, R; Makis, W; Novales-Diaz, JA | 1 |
Cho, SB; Chung, CY; Joo, YE; Kim, JS; Lee, WS; Min, JJ; Myung, DS; Park, HC | 1 |
Cho, I; Chun, K; Jang, B; Jeong, J; Kim, S; Kim, T; Kong, E; Song, S | 1 |
Chen, L; Cui, JX; Li, T; Wei, B; Xi, HQ | 1 |
Izuishi, K; Kameyama, R; Masaki, T; Mori, H; Suzuki, Y; Takebayashi, R; Yamamoto, Y | 1 |
Hartnett, GF; Lee, JC; Ravi Kumar, AS | 1 |
Jeon, TJ; Kim, JH; Lee, SI; Lee, YC; Ma, DW; Park, H; Youn, YH; Yun, M | 1 |
Shim, KN; Yun, HW | 1 |
Hanazaki, K; Kobayashi, M; Namikawa, T; Nogami, M; Ogawa, Y; Okabayshi, T | 1 |
Ding, Q; Ding, QC; Dong, P; Gu, J; Li, ML; Liu, YB; Lu, JH; Tan, ZJ; Weng, H; Wu, WG; Wu, XS; Yang, JH; Zhang, L | 1 |
Blazeby, JM; Blencowe, NS; Callaway, M; Ganesh, S; Hotton, EJ; Roach, H; Strong, S; Whistance, RN | 1 |
Hojo, S; Nagata, T; Nomoto, K; Okumura, T; Sawada, S; Shimada, Y; Tsukada, K | 1 |
Cheon, GJ; Chung, JK; Go, H; Lee, DS; Seo, HJ | 1 |
Albarello, L; Ambrosi, A; Canevari, C; Castiglioni, I; De Cobelli, F; Del Maschio, A; Esposito, A; Gallivanone, F; Gianolli, L; Giganti, F; Mazza, E; Orsenigo, E; Staudacher, C | 1 |
Bal, C; Gupta, SK; Karunanithi, S; Kumar, R; Lata, S; Malhotra, A; Naswa, N; Patnecha, M; Reddy, RM; Sharma, P | 1 |
Chong, S; Coupe, NA; Karikios, D; Lin, M; Merrett, N; Ng, W; Yap, J | 1 |
Beppu, K; Himeji, D; Kawano, N; Kuriyama, T; Masuyama, H; Ono, N; Oshima, K; Oyama, M; Shimao, Y; Ueda, A; Ueda, Y; Yamaguchi, K; Yamashita, K; Yoshida, S | 1 |
Bergestuen, DS; Khan, MS; Kim, MK; Oberg, K; Rinke, A; Salazar, R; Thirlwell, C; Toumpanakis, C | 1 |
Ansaloni, L; Baiocchi, GL; Capponi, MG; Coniglio, A; D'Ugo, D; De Manzoni, G; Di Leo, A; Giacopuzzi, S; Giulini, SM; Marchet, A; Marrelli, D; Morgagni, P; Nitti, D; Pacelli, F; Rosa, F; Roviello, F; Saragoni, L; Tiberio, GA; Verlato, G | 1 |
Inoue, T; Jinnouchi, S; Minamimoto, R; Senda, M; Terauchi, T; Yoshida, T | 1 |
Chong, A; Ha, JM; Hong, R; Lee, HJ; Park, SG | 1 |
Kwee, RM; Kwee, TC | 1 |
Aguilar-Barrios, JE; Cózar-Santiago, Mdel P; Devis-Saiz, M; Ferrer-Rebolleda, J; Sánchez-Jurado, R; Sanz-Llorens, R | 1 |
Adams, HL; Jaunoo, SS | 1 |
Wu, CX; Zhu, ZH | 1 |
Irie, T; Izumiyama, K; Miyashita, K; Miyazaki, M; Mori, A; Morioka, M; Saito, M; Tanaka, M; Tanaka, S; Tanino, M; Tsukamoto, E | 1 |
Basturk, A; Kilicarslan, A; Ozdemir, E; Turkolmez, S; Yildirim-Poyraz, N | 1 |
Baba, H; Baba, Y; Ida, S; Ishimoto, T; Iwagami, S; Iwatsuki, M; Miyamoto, Y; Nagai, Y; Sakamoto, Y; Watanabe, M; Yamao, T | 1 |
Choi, SR; Kim, JM; Kim, KS; Koo, TH; Park, IC | 1 |
Lee, CH; Lee, DY; Lee, JJ; Lee, SH; Ryu, JS; Seo, MJ | 1 |
Banzo, I; Carril, JM; Jiménez-Bonilla, J; Martínez-Rodríguez, I; Quirce, R | 1 |
Bomanji, J; Panagiotidis, E | 1 |
Mortensen, MB | 1 |
Cappetta, A; Evangelista, L; Opocher, G; Pastorelli, D; Spano, L; Zovato, S | 1 |
Kim, H; Kim, SJ; Pak, K; Shin, S | 1 |
Bots, M; Cullinane, C; Martin, BP; Newbold, A | 1 |
Bahri, H; Boucher, E; Clement, B; Cuggia, M; Devillers, A; Edeline, J; Garin, E; Laurence, L; Leghzali, H; Mesbah, H; Raoul, JL | 1 |
Dong, M; Li, W; Li, Y; Sun, X; Xing, L | 1 |
Doudouh, A; El Hammoumi, M; El Marjany, M; Kabiri, el H; Mansouri, H; Moussaoui, D | 1 |
Adalet, I; Aykan, F; Has Simsek, D; Kuyumcu, S; Sanlı, Y; Turkmen, C; Unal, S | 1 |
Schillaci, O | 1 |
Chen, J; Liu, J; Zheng, W; Zhou, Z; Zuo, C | 1 |
Carney, JA; Chen, CC; Papadakis, GZ; Patronas, NJ; Stratakis, CA | 1 |
Choi, JY; Jung, HK; Jung, SA; Kim, SE; Shim, KN; Yoo, K | 1 |
Colletti, PM; Fernández-Esparrach, G; Fuster, D; Mayoral, M; Pagès, M; Pineda, E; Pons, F; Rubello, D | 1 |
Choi, JY; Kim, JJ; Lee, JH; Min, BH; Rhee, PL; Tae, CH | 1 |
Huang, YT; Lin, M; Yap, J | 1 |
Duong, C; Hicks, RJ; Kaneko, Y; Link, E; Murray, WK | 1 |
Hicks, RJ; Hofman, MS; Kashyap, R; Michael, M | 1 |
Edeline, J; Garin, E | 1 |
Han, EJ; Kim, SH; O, JH; Park, HL; Yoo, IeR | 1 |
Altini, C; Di Palo, A; Fanelli, M; Ferrari, C; Moschetta, M; Niccoli Asabella, A; Rubini, G | 1 |
Bang, YJ; Han, SW; Im, SA; Kim, TY; Lee, KH; Ock, CY; Oh, DY | 1 |
d'Amico, A; Grabinska, K; Pelak, M; Tukiendorf, A; Wydmanski, J | 1 |
Donswijk, ML; Hess, S; Lam, MG; Mulders, T | 1 |
Cui, XJ; Fang, N; Wang, YL; Wu, ZJ; Zeng, L | 1 |
Hickeson, M; Lisbona, R; Malibari, N | 1 |
Kang, YN; Kim, HW; Ryu, SW; Sohn, SS; Song, BI; Won, KS | 1 |
Cho, A; Jo, K; Lee, JD; Lee, JW; Noh, SH; Yun, M | 1 |
Cui, J; Liu, B; Ren, Z; Zhao, P | 1 |
Cai, L; Hou, J; Li, B; Shi, H; Zhang, Y; Zhou, J | 1 |
Makis, W | 1 |
Ajani, JA; Badgwell, BD; Bhutani, MS; Blum, MA; Charalampakis, N; Das, P; Elimova, E; Estrella, JS; Lee, JH; Matamoros, A; Planjery, V; Rogers, JE; Sagebiel, T; Shimodaira, Y; Shiozaki, H; Wadhwa, R; Weston, B; Xiao, L | 1 |
Galloway, S; Mirza, A | 1 |
Cabalag, CS; Callahan, J; Duong, CP; Hicks, RJ; Le Roux, PY; Parameswaran, BK | 1 |
Kim, CG; Kim, DW; Kim, MH | 1 |
Guo, W; Ji, D; Li, J; Li, W; Liu, X; Tao, Z; Wang, C; Zhang, X; Zhang, Y; Zhou, M; Zhu, X | 1 |
Lee, JW; Lee, MS; Lee, SM; Son, MW | 1 |
Han, JK; Im, SA; Kim, SH; Kim, TY; Lee, DH; Oh, DY | 1 |
Abe, H; Aikou, S; Fukayama, M; Jinbo, K; Koyama, K; Matsusaka, K; Momose, T; Mori, K; Nomura, S; Okumura, Y; Onoyama, H; Seto, Y; Takahashi, M; Ushiku, T; Yamagata, Y; Yamashita, H | 1 |
Bae, JM; Cho, YS; Choe, YS; Kim, BT; Kim, S; Kim, SJ; Lee, KH; Moon, SH | 1 |
Huang, G; Li, P; Liu, J; Liu, Q; Song, S; Wang, C; Wang, T | 1 |
Cheong, JH; Cho, A; Chung, HC; Hyung, WJ; Jung, M; Kang, B; Kim, H; Kim, HI; Kim, HS; Lim, SM; Noh, SH; Rha, SY; Yun, M | 1 |
Cai, Y; Cheng, Z; Lu, T; Nan, Y; Yin, C | 1 |
Chen, R; Huang, G; Liu, J; Zhou, X | 1 |
Koike, T; Nagasawa, A; Namura, O; Okamoto, T; Tsuchida, M | 1 |
Hwang, JW; Jee, SR; Kim, JH; Lee, SH; Lee, SM; Seol, SY | 1 |
Abraham, T; Da Silva, R; Friedmann, P; Goldman, I; Huang, K; Kennedy, TJ; Libutti, SK; Love, C; Ng, N; Serrano, OK | 1 |
Doi, H; Fukushima, K; Hirota, S; Kaibe, N; Kawanaka, Y; Kitajima, K; Miwa, H; Mouri, M; Niwa, H; Oshima, T; Sasako, M; Tomita, T | 1 |
Han, JK; Hur, BY; Joo, I; Kim, SH; Lee, DH | 1 |
Jinguji, M; Kajiya, Y; Nakajo, M; Tani, A; Yoshiura, T | 1 |
Bilgin, M; Bilgin, SS; Erdogan, EB; Savas, R | 1 |
Byun, BH; Choi, CW; Hwang, JP; Kim, BI; Lim, I; Lim, SM | 1 |
Choi, MG; Lee, HH; Lee, SH; Na, SJ; o, JH; Park, CH; Park, JM; Song, KY | 1 |
Bae, SU; Cho, KB; Choi, BW; Kim, HW; Song, BI; Won, KS | 1 |
Albano, D; Bertagna, F; Bertoli, M; Fallanca, F; Ferro, P; Gianolli, L; Giubbini, R; Picchio, M | 1 |
Law, SY; Lee, EY; Lo, AW; Vardhanabhuti, V | 1 |
Dolak, W; Karanikas, G; Kiesewetter, B; Kletter, K; Lukas, J; Mayerhoefer, ME; Müllauer, L; Pones, M; Raderer, M; Rausch, I; Simonitsch-Klupp, I; Weber, M | 1 |
Dai, D; Dong, YW; Fu, Q; Li, XF; Liu, JJ; Song, XY; Xu, WG; Zuo, C | 1 |
Abdul-Rahman, H; Bauerfeind, P; Eshmuminov, D; Fischer, M; Gubler, C; Lehmann, K; Reiner, C; Schneider, PM; Veit-Haibach, P; Weber, A | 1 |
Chikuta, I; Edo, N; Ishikawa, T; Mashimo, Y; Masugi, H; Morita, K; Ota, S; Sakamoto, T; Seki, N; Tokairin, T | 1 |
Kudithipudi, V; Maheshwary, R; Nguyen, D; Rajput, A; Tran, C | 1 |
Colletti, PM; Dubreuil, J; Giammarile, F; Glehen, O; Rousset, P; Rubello, D; Skanjeti, A | 1 |
Ding, LY; Jiang, ZL; Liu, KJ; Wu, HY; Wu, SX | 1 |
Buck, AK; Higuchi, T; Lapa, C; Samnick, S; Schirbel, A; Weich, A; Werner, RA; Wester, HJ | 1 |
Cho, A; Hong, JW; Hyung, WJ; Ku, CR; Kwon, IG; Lee, EJ; Lee, N; Noh, SH; Yun, M | 1 |
Lu, P; Shen, B; Wang, X; Wei, Y; Xue, Y; Yu, L | 1 |
Ding, B; Lin, H; Qu, Y; Yan, F; Yang, G; Zhang, H; Zhang, M | 1 |
Chong, S; Coupe, N; Lee, S; Lin, M; Manoharan, V; Merrett, N; Ng, W; Wilson, R; Yap, J | 1 |
Enomoto, K; Hamada, K; Hatazawa, J; Higuchi, I; Inohara, H; Kubo, T; Tomita, Y | 1 |
Choi, JY; Kim, BT; Lee, WJ; Lim, HK; Park, KW; Park, MJ | 1 |
Guan, YS; Luo, ZM; Pan, WM; Su, XH; Sun, L; Wei, JH; Wu, H | 1 |
Cheng, MF; Tzen, KY; Wang, SY; Yen, RF | 1 |
Breen, S; Brock, K; Cheung, F; Darling, G; Dinniwell, R; Grabarz, D; Haider, M; Kamra, J; Knox, J; Mah, K; Mansouri, A; Pond, G; Ung, Y; Vesprini, D; Wong, RK | 1 |
Almusa, O; Daly, B; Shreve, P | 1 |
Haba, R; Hagiike, M; Izuishi, K; Kaji, M; Kameyama, R; Murota, M; Nishiyama, Y; Takebayashi, R; Yamamoto, Y | 1 |
Hasegawa, Y; Hyodo, I; Nakashima, T; Nishio, M; Ogawa, T; Suzuki, H; Suzuki, M; Tamaki, T; Terada, A | 1 |
Tulchinsky, M | 1 |
de Leval, L; Delrez, R; Depas, G; Dresse, MF; Etienne, I; Forget, P; Guidi, O; Hoyoux, C; Jacquemart, C | 1 |
Arslan, N; Ataergin, S; Ozet, A; Ozguven, MA | 1 |
Bosscha, K; Dassen, AE; Hoekstra, CJ; Lips, DJ; Pruijt, JF | 1 |
Abood, G; Aranha, GV; Moreira, J; Nagda, S; Shoup, M; Smith, JW; Wagner, RH | 1 |
Bang, YJ; Heo, DS; Im, SA; Kang, WJ; Kim, DW; Kim, TY; Kim, WH; Kim, YJ; Lee, SH; Oh, DY; Sim, SH | 1 |
Amrouche, L; Bourgarit, A; Farge, D; Florea, L; George, C; Gornet, JM; Lascoux, C; Séréni, D | 1 |
Fujii, H; Fukuda, H; Kaneta, T; Kitajima, K; Kubota, K; Murakami, K; Nakajima, K; Nakamoto, Y; Satake, M; Senda, M; Tateishi, U; Togashi, K | 1 |
Fujimoto, T; Fujita, S; Inoue, T; Kamimura, K; Komada, N; Nagamachi, S; Nakajo, M; Nishii, R; Ogita, M; Sakurai, T; Umemura, Y; Wakamatsu, H | 1 |
Chino, A; Fujisaki, J; Fujita, R; Hayashi, Y; Igarashi, M; Ishiyama, A; Kato, K; Koyama, M; Kuraoka, K; Ohkawa, N; Takahashi, H; Tsuchida, T; Ueki, N; Ukawa, K; Uragami, N; Yamamoto, Y; Yamashita, T; Yoshimoto, K | 1 |
Fujiwara, H; Kaneda, K; Kizaki, T; Nishimura, T; Sendo, H; Shirakawa, S; Wada, T | 1 |
Choi, JY; Kim, BT; Kim, SJ; Kim, WS; Ko, YH; Yi, JH | 1 |
Akazawa, K; Kubota, T; Matsushima, S; Nishida, K; Nishimura, T; Oda, M; Okuyama, C | 1 |
Gamble, B; Ho, L; Meka, M | 1 |
Hiyama, A; Matsunaga, N; Suga, K; Takeda, K; Yasuhiko, K | 1 |
Hiyama, A; Kawakami, Y; Matsunaga, N; Suga, K; Takeda, K; Tanizawa, Y | 1 |
Avisar, E; Goodwin, WJ; Moffat, FL; Molina, MA; Serafini, AN; Sfakianakis, GN | 1 |
Akamatsu, T; Furuya, N; Hiraga, R; Koide, N; Komatsu, D; Miyagawa, S; Uehara, T | 1 |
Takada, M; Yamamoto, S | 1 |
Choi, BW; Kim, HW; Won, KS; Zeon, SK | 1 |
Chihara, D; Ine, S; Kagami, Y; Kato, H; Morishima, Y; Oki, Y; Onoda, H; Taji, H; Yamamoto, K | 1 |
Asada, Y; Fujisawa, K; Iida, Y; Kawaguchi, M; Mitsui, T; Miura, S; Munemoto, Y; Sudo, Y; Takehara, A; Terada, T | 1 |
Alakus, H; Baldus, SE; Batur, M; Bollschweiler, E; Drebber, U; Hölscher, AH; Metzger, R; Mönig, SP; Prenzel, KL; Schmidt, M; Vallböhmer, D | 1 |
Hase, K; Hiraki, S; Ichikura, T; Ono, S; Sakamoto, N; Shimazaki, H; Sugasawa, H; Tsujimoto, H; Yaguchi, Y; Yamamoto, J | 1 |
Abikhzer, G; Makis, W; Stern, J | 1 |
Cho, YH; Chung, HW; Kim, JH; Kim, SY; Lee, EJ; Lee, KY; Lee, MH; Lee, SY; Park, HS; So, Y; Sung, IK; Yoo, MW; Yoon, SY | 1 |
Li, J; Liu, Y; Wang, JW; Xu, LM; Zhao, S | 1 |
Ajani, JA; Bhutani, MS; Hofstetter, WL; Lee, JH; Liao, Z; Macapinlac, HA; Murthy, SB; Patnana, SV; Rohren, E; Swisher, SG; Wang, X; Xiao, L | 2 |
August, DA; Gannon, C | 1 |
Alakus, H; Baldus, S; Bollschweiler, E; Brabender, J; Dietlein, M; Hölscher, AH; Metzger, R; Mönig, SP; Schmidt, M; Schneider, PM; Vallböhmer, D | 1 |
Sendler, A | 1 |
Bilici, A; Canpolat, N; Gumus, M; Kefeli, U; Ozugur, S; Seker, M; Tekinsoy, B; Ustaalioglu, BB | 1 |
Hur, H; Jeon, HM; Kim, SH; Kim, W; Park, CH; Song, KY | 1 |
Krause, BJ; Lordick, F; Ott, K | 2 |
Alekshun, TJ; Rai, M; Rustagi, T | 1 |
Billotey, C; Borson-Chazot, F; Bournaud, C; Cornu, C; Giammarile, F; Hervieu, V; Houzard, C; Janier, M; Le Bars, D; Lombard-Bohas, C; Masson, S; Scoazec, JY; Vuillez, JP; Walter, T | 1 |
Ahn, DH; Hong, SP; Hwang, SG; Jeon, TJ; Kang, MK; Ko, KH; Kwon, CI; Lee, JE; Park, PW; Rim, KS | 1 |
Hornick, JL; Jagannathan, JP; LaCasce, AS; O'Regan, K; Ramaiya, NH; Shinagare, AB | 1 |
Kita, M; Kitajima, K; Maeda, T; Ohno, Y; Onishi, Y; Senda, M; Sugimura, K; Suzuki, K; Yoshikawa, T | 1 |
Koyama, M; Murakami, K; Okazumi, S; Shimada, H | 1 |
Herrmann, K; Krause, BJ; Wieder, HA | 1 |
Ahmad, A; Barakat, FH; Chuang, HH; Fowler, NH; Habra, MA; Myers, JN; Shahani, S; Stava, C | 1 |
Becker, K; Buck, AK; Ebert, MP; Herrmann, K; Krause, BJ; Langer, R; Lordick, F; Ott, K; Peschel, C; Schuster, T; Schwaiger, M; Siewert, JR; Wester, HJ; Wieder, HA; Wilhelm, D; zum Büschenfelde, CM | 1 |
Choi, IS; Choi, WJ; Kang, YH; Lee, SE; Min, HS; Moon, JI; Oh, HH; Ra, YM; Yoon, DS | 1 |
Cheong, JH; Choi, SH; Hyung, WJ; Noh, SH; Pak, KH; Yun, M | 1 |
Ciarallo, A; Makis, W; Michel, RP; Novales-Diaz, JA | 1 |
Lindner, A; Manger, B; Manger, K; Schett, G; Wacker, J | 1 |
Kim, CG; Kim, DW; Park, SA | 1 |
Araz, M; Kucuk, ON; Ozkan, E; Soydal, C | 1 |
Aihara, R; Ando, H; Asao, T; Kato, T; Kogure, N; Kuwano, H; Mochiki, E; Ogata, K; Ohno, T; Oyama, T; Sakurai, S; Sano, A; Zai, H | 1 |
Gu, HY; Hu, JN; Hua, J; Wu, LM; Xu, JR; Zhu, J | 1 |
Akamatsu, T; Arakura, N; Haba, S; Ishida, F; Ito, T; Iwaya, Y; Kaneko, Y; Matsuda, K; Muraki, T; Nakazawa, H; Sano, K; Takenaka, K; Tanaka, E; Yamada, Y | 1 |
Dong, MJ; Ouyang, XB; Pan, JH | 1 |
Kajiya, Y; Nakajo, M; Shimaoka, S; Tanaka, S; Tani, A | 1 |
Shah, MA; Smyth, EC | 1 |
Ciarallo, A; Hickeson, M; Lisbona, R; Makis, W | 1 |
Ciarallo, A; Hickeson, M; Makis, W | 1 |
Henderson, R; Ho, L; Nakla, A; Wassef, H | 1 |
Alakus, H; Berthold, F; Dietlein, M; Drebber, U; Hero, B; Holinski-Feder, E; Schmidt, MC; Schneider, C; Simon, T; Uphoff, US | 1 |
Han, A; Hu, M; Wang, X; Xue, J; Zheng, J | 1 |
Cheoi, K; Chung, H; Lee, H; Lee, JH; Lee, SK; Lee, YC; Park, JC; Shin, SK; Yun, MJ | 1 |
Capanu, M; Coit, DG; Kelsen, DP; Schöder, H; Shah, MA; Smyth, E; Strong, VE | 1 |
Cho, YK; Choi, MG; Chung, IS; Jung, HS; Lee, IS; Park, CH; Park, JM; Song, KY; Yoon, NR | 1 |
Amano, Y; Kato, S; Kumita, S; Machida, T; Naito, Z; Takeda, M | 1 |
Lee, JW; Lee, MS; Lee, SM; Shin, HC | 1 |
Jadvar, H | 1 |
Chung, HW; Han, HS; Lee, HH; Lee, SY; Park, HS; So, Y; Yang, JH | 1 |
Bal, C; Kumar, R; Malhotra, A; Reddy, RM; Sharma, A; Sharma, P; Singh, H; Suman, SK; Thulkar, S | 1 |
Jeon, HM; Kim, SH; O, JH; Oh, SI; Park, CH; Shim, JH; Song, KY; Yoo, HM | 1 |
Sugimura, H | 1 |
Jujo, T; Oide, T; Sakao, S; Tatsumi, K | 1 |
Chin, HM; Chung, WC; Jeon, HS; Jun, KH; Kim, JH; Lee, H; Lee, KM; Paik, CN | 1 |
Honndorf, V; Kukuk, D; Mannheim, JG; Mueller, A; Pichler, BJ; Reischl, G; Röse, L; von Ahsen, O; Wiehr, S | 1 |
Cheng, J; Dai, D; Ma, WC; Song, XY; Xu, WG; Xu, XX; Zhu, L; Zhu, X | 1 |
Bae, WK; Cho, SH; Chung, IJ; Hwang, JE; Lee, JH; Park, MR; Park, MS; Shim, HJ | 1 |
Bal, C; Kumar, R; Malhotra, A; Sharma, A; Sharma, P; Singh, H; Suman, SK | 1 |
Eker, O; Kamali, G; Mulazimoglu, M; Ozpacaci, T; Tamam, MO | 1 |
Hayabuchi, N; Hirose, Y; Ishibashi, M; Kaida, H; Miura, M; Miyazaki, K; Nakahara, K; Ogo, E; Ohshima, K; Okamura, T; Suefuji, H; Suzuki, G; Takasu, K; Uozumi, J; Watanabe, Y | 1 |
Fan, Y; Fu, L; Li, H; Tian, J; Wang, H; Xu, B | 1 |
Aktas, B; Aras, M; Dane, F; Dede, F; Turoglu, HT | 1 |
Choi, BW; Hwang, I; Jo, I; Kim, SH; Won, KS; Zeon, SK | 1 |
Becherer, A; Hoffmann, M; Kletter, K; Oberhuber, G; Raderer, M | 1 |
Becker, K; Fink, U; Link, T; Ott, K; Schwaiger, M; Siewert, JR; Stahl, A; Weber, WA | 1 |
Conti, PS; Garcia, AA; Jadvar, H; Tatlidil, R | 1 |
Fink, U; Ott, K; Siewert, JR; Weber, W | 1 |
Fukuda, H; Ido, T; Kanamaru, R; Kubota, K; Saginoya, T; Takahashi, H; Yamaguchi, K; Yamaura, G; Yamazaki, T; Yoshioka, T | 1 |
Bourguet, P | 1 |
Chin, BB; Wahl, RL | 1 |
Becker, K; Fink, U; Helmberger, H; Müller, J; Ott, K; Schwaiger, M; Siewert, JR; Stein, HJ; Weber, WA | 1 |
Larson, SM; Macapinlac, HA; Salmon, AS; Turlakow, A; Yeung, HW | 1 |
Becker, K; Busch, R; Dittler, HJ; Fink, U; Link, T; Lordick, F; Ott, K; Schwaiger, M; Siewert, JR; Stahl, A; Stein, H; Weber, WA | 1 |
Berlangieri, SU; Ollenberger, GP | 1 |
Asao, T; Endo, K; Katoh, H; Kuwano, H; Mochiki, E; Oriuchi, N | 1 |
Flamen, P | 1 |
Fujita, T; Higashi, T; Ishimori, T; Ishizu, K; Kato, H; Konishi, J; Mamede, M; Matsumoto, K; Mukai, T; Saga, T; Sato, S; Senda, M; Yamaoka, Y | 1 |
Dehdashti, F; Siegel, BA | 1 |
Alavi, A; Kung, JW; Potenta, S; Xiu, Y; Yu, JQ; Zhuang, H | 1 |
Ott, K; Schwaiger, M; Stahl, A; Weber, WA | 1 |
Chen, L; Ding, Y; Shao, M; Tian, J; Wei, B; Yao, S; Yin, D | 1 |
Chen, B; Kou, QL; Li, R; Liu, XB; Lu, yL; Wei, B; Yao, sL | 1 |
Chu, XY; Liu, Y; Sun, YE; Tian, JH; Wang, T | 1 |
Canessa, JA; Galaz, R; González, P; Humeres, P; Jofré, J; Larach, JA; Massardo, T; Morales, B; Parra, J; Sierralta, P | 1 |
Bonenkamp, JJ; de Bruin, JH; Drenth, JP; Ligtenberg, MJ; Nagengast, FM; Oyen, WJ; van Kouwen, MC; van Krieken, JH | 1 |
Ak, I; Gülbaş, Z | 1 |
Adler, LP; Buyyounouski, MK; Klump, WJ; Konski, A; Wu, H | 1 |
Bueno, JG; Domínguez Grande, ML; Fernández, JP; Kosvintseva, O; Oromendía, AO; Pozo, MA; Suárez, AM; Zomeño, M | 1 |
Kato, H; Kuwano, H; Sohda, M | 1 |
Kubota, T; Nakai, T; Nishimura, T; Okuyama, C; Ushijima, Y | 1 |
Chen, J; Cheong, JH; Hyung, WJ; Kim, J; Lim, JS; Noh, SH; Yun, MJ | 1 |
Bong, JK; Choi, HS; Lee, JD; Ryu, YH; Yoo, E; Yun, M | 1 |
Takei, M | 1 |
Bong, JK; Cheong, JH; Cho, A; Hyung, WJ; Lee, JD; Lim, JS; Noh, SH; Yun, M | 1 |
Bae, JM; Chang, HJ; Choi, JY; Kang, KW; Kim, HK; Kim, SK; Kim, YW; Lee, JH; Lee, JS; Ryu, KW | 1 |
Chott, A; Hoffmann, M; Raderer, M; Streubel, B; Woehrer, S | 1 |
Bandou, H; Ishiguro, K; Kinoshita, S; Koizumi, H; Kotake, M; Murakami, N; Yamada, T | 1 |
Alavi, A; Bhutain, C; Chamroonrat, W; El-Haddad, G; Houseni, M; Mavi, A; Zhuang, H | 1 |
Ak, I; Aydemir, B; Gülbaş, Z | 1 |
Esteves, FP; Halkar, RK; Schuster, DM | 1 |
Hisada, K; Kageyama, M; Kamisaki, Y; Kato, H; Kawabe, H; Matsunari, I; Murakami, J; Seto, H; Shimizu, M; Watanabe, N | 1 |
Chang, P; Sun, K; Sun, YE; Tian, JH; Wang, T; Wu, X; Yang, B; Yao, SL; Yu, CH | 1 |
Al-Nahhas, A; Alavi, A; Ambrosini, V; Castellucci, P; Fanti, S; Farsad, M; Nanni, C; Rubello, D; Tehranipour, N; Zinzani, P | 1 |
Arikawa, S; Baba, K; Hayabuchi, N; Ishibashi, M; Kaida, H; Nakamura, M; Tahara, N; Tomita, N; Uozumi, J | 1 |
Chang, CC; Hsu, CH; Lin, YH; Liu, JD; Tai, CJ | 1 |
Ishida, Y; Isozaki, H; Morimoto, T; Mukai, K; Nishiyama, S; Okajima, K | 1 |
Becker, K; Busch, R; Fink, U; Herrmann, K; Lordick, F; Ott, K; Schwaiger, M; Siewert, JR; Weber, WA; Wieder, H | 1 |
Blake, MA; Blaszkowsky, LS; Fischman, A; Holalkere, NS; Setty, B | 1 |
Goto, M; Higashi, T; Mizumatsu, S; Nishimura, T; Sakai, K; Sugatani, H | 1 |
Blondet, C; Cimarelli, S; Contantinesco, A; Imperiale, A; Sellem, DB | 1 |
Li, F; Zhu, Z; Zhuang, H | 1 |
Chen, X; Dai, JZ; Dong, MJ; Guan, YH; Jiang, BD; Lin, XT; Zhao, J; Zuo, CT | 1 |
Fukushima, M; Imai, Y; Kadoya, M; Oguchi, K; Yamada, A | 1 |
Bhure, U; Hany, TF; Pestalozzi, BC; Schmitt, AM; Strobel, K | 1 |
Bourguet, P; Metges, JP; Mitry, E; Monteil, J; Planchamp, F; Tubiana-Mathieu, N | 1 |
Hayasaka, K; Ishigaki, T; Ito, K; Itou, T; Kato, R; Nihashi, T; Okae, T | 1 |
Ando, T; Goto, H; Hirooka, Y; Itoh, A; Maeda, O; Matsuura, T; Miyahara, R; Niwa, Y; Ohashi, A; Ohmiya, N; Yamada, M | 1 |
Bellati, F; Boni, T; Manci, N; Marchetti, C; Morano, G; Panici, PB; Pernice, M | 1 |
Baird, GS; Kanne, JP; Livingston, RB; Mankoff, DA; Minoshima, S | 1 |
Antoch, G; Beyer, T; Bockisch, A; Hauth, EA; Schleucher, R; Stergar, H; Veit-Haibach, P | 1 |
Binns, DS; Drummond, E; Hicks, RJ; Hogg, A; Lau, EW; Shakher, R; Wang, GH | 1 |
Park, KG; Smith, TA; Suttie, SA | 1 |
Becker, K; Buck, AK; Herrmann, K; Krause, BJ; Lordick, F; Ott, K; Schuster, T; Schwaiger, M; Siewert, JR; Souvatzoglou, M; Wester, HJ; Wilhelm, D | 1 |
Guan, YS; Sun, L; Wu, H; Ye, HY; Zhang, YH | 1 |
Daisaki, H; Hamashima, C; Kakugawa, Y; Kozu, T; Moriyama, N; Muramatsu, Y; Saito, D; Saito, H; Shoda, H; Terauchi, T | 1 |
Bredenkamp, R; Hennig, M; Herrmann, K; Lordick, F; Lorenzen, S; Ott, K; Peschel, C; Schwaiger, M; Weber, WA; Wieder, H | 1 |
Castellucci, P; Di Fabio, F; Fanti, S; Funaioli, C; Giaquinta, S; Longobardi, C; Martoni, AA; Mutri, V; Pinto, C; Rojas Llimpe, FL; Sperandi, F | 1 |
Cheng, W; Cheng, X; Dang, Y; Li, F; Mao, Y; Zhu, Z | 1 |
Herrmann, K; Krause, BJ; Lordick, F; Ott, K; Schuhmacher, C; Siewert, JR | 1 |
Becker, K; Buck, AK; Dobritz, M; Fink, U; Herrmann, K; Krause, BJ; Lordick, F; Ott, K; Schuster, T; Schwaiger, M; Siewert, JR; Ulm, K; Weber, WA; Wieder, H | 1 |
Bar-Shalom, R; Dann, EJ; Epelbaum, R; Fischer, D; Gaitini, D; Haim, N; Israel, O; Radan, L | 1 |
Jeong, HJ; Kim, DW; Lim, ST; Sohn, MH; Yim, CY | 1 |
Castell, F; Cook, GJ | 1 |
Kanamaru, R; Oikawa, H; Takahashi, H; Yoshioka, T | 1 |
Akaizawa, T; Fukuda, H; Ido, T; Kanamaru, R; Maeda, S; Oikawa, H; Takahashi, H; Yoshioka, T | 1 |
Cronin, V; Galantowicz, P; Nabi, HA | 1 |
Adams, S; Baum, R; Hör, G; Rink, T; Schumm-Dräger, PM; Usadel, KH | 1 |
Ahlström, H; Glimelius, B; Hagberg, H; Rehn, S; Rodriguez, M; Sundín, A; Sundström, C | 1 |
Rodriguez, M | 1 |
Wagner, HN | 1 |
Couper, GW; McAteer, D; Nicolson, M; Norton, M; Park, KG; Wallis, F; Welch, A | 1 |
Bruce, D; Couper, G; Gilbert, FJ; McAteer, D; Nicolson, M; Norton, M; Park, K; Sharp, P; Wallis, F; Welch, A | 1 |
Coosemans, W; De Leyn, P; De Wever, W; Decker, G; Deneffe, G; Ectors, N; Flamen, P; Hiele, M; Lerut, T; Mortelmans, L; Peeters, M; Van Cutsem, E; Van Raemdonck, D | 1 |
Aigner, RM; Karpf, E; Schwarz, T; Wurzinger, G | 1 |
Andersson, LC; Capdeville, R; Demetri, GD; Dimitrijevic, S; Druker, B; Joensuu, H; Roberts, PJ; Sarlomo-Rikala, M; Silberman, S; Tervahartiala, P; Tuveson, D | 1 |
Bormans, G; De Potter, T; Filez, L; Flamen, P; Maes, A; Mortelmans, L; Penninckx, F; Van Cutsem, E | 1 |
Fukuda, H; Ido, T; Ito, M; Maeda, S; Matsuzawa, T; Takahashi, H; Wakui, A; Yamaguchi, K; Yang, PK | 1 |
46 review(s) available for fluorodeoxyglucose f18 and Stomach Neoplasms
Article | Year |
---|---|
State-of-the-art imaging in oesophago-gastric cancer.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2022 |
The impact of baseline
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2022 |
PET/CT for Predicting Occult Lymph Node Metastasis in Gastric Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Stomach Neoplasms | 2022 |
Fibroblast Activation Protein Inhibitor PET/CT in Gastric Cancer.
Topics: Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Stomach Neoplasms | 2023 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis.
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms | 2023 |
Ga-68 DOTA-peptides and F-18 FDG PET/CT in patients with neuroendocrine tumor: A review.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Intestinal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Stomach Neoplasms | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Prognostic value of pretreatment standardized uptake value of F-18-fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysis.
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Stomach Neoplasms | 2017 |
Positron emission tomography/computer tomography in gastrointestinal malignancies: current potential and challenges.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
PET/Computed Tomography and Precision Medicine: Gastric Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Precision Medicine; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update.
Topics: Animals; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2017 |
[Evaluation of (18)F-FDG PET/CT in preoperative staging of gastric cancer: a meta-analysis].
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
[Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies].
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Stomach Neoplasms | 2013 |
Combination of cross-sectional and molecular imaging studies in the localization of gastroenteropancreatic neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Magnetic Resonance Imaging; Molecular Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radionuclide Imaging; Receptors, Somatostatin; Sensitivity and Specificity; Stomach Neoplasms; Surveys and Questionnaires; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Molecular Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Stomach Neoplasms; Treatment Outcome | 2014 |
Diagnosis and evaluation of gastric cancer by positron emission tomography.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Role of 18F-fluorodeoxyglucose PET in the study of neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Enterochromaffin Cells; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms | 2014 |
Novel imaging strategies for upper gastrointestinal tract cancers.
Topics: Diagnostic Imaging; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Endosonography; Esophageal Neoplasms; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Neoplasm Invasiveness; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Is there a role for PET/CT with esophagogastric junction adenocarcinoma?
Topics: Adenocarcinoma; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Improving patient selection for 18F-FDG PET scanning in the staging of gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Observer Variation; Patient Selection; Positron-Emission Tomography; Prospective Studies; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2015 |
[18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Humans; Lymph Nodes; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Fluorine-18-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer after surgical resection: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Stomach Neoplasms | 2016 |
18F-FDG-PET/CT of peritoneal tumors: a pictorial essay.
Topics: Carcinoma; Desmoplastic Small Round Cell Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Mesothelioma; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Pseudomyxoma Peritonei; Radiopharmaceuticals; Sarcoma; Stomach Neoplasms | 2017 |
FDG-PET has no definite role in preoperative imaging in gastric cancer.
Topics: Chemotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm Staging; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, Emission-Computed | 2009 |
Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biopsy; Chemotherapy, Adjuvant; Drug Combinations; Fatal Outcome; Fluorodeoxyglucose F18; Gastrectomy; Gastroscopy; Granulocyte Colony-Stimulating Factor; Humans; Leukocytosis; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Splenectomy; Stomach Neoplasms; Tegafur; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Metabolic response evaluation by PET during neoadjuvant treatment for adenocarcinoma of the esophagus and esophagogastric junction.
Topics: Adenocarcinoma; Endosonography; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2010 |
New trends for staging and therapy for localized gastroesophageal cancer: the role of PET.
Topics: Adenocarcinoma; Algorithms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Medical Oncology; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Stomach Neoplasms; Treatment Outcome | 2010 |
Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Gastric Mucosa; Glucose Transporter Type 1; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms; Treatment Outcome | 2011 |
[Positron emission tomography - current role in the diagnosis and treatment of upper gastrointestinal carcinomas].
Topics: Adenocarcinoma; Combined Modality Therapy; Dideoxynucleosides; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
[Hypertrophic osteoarthropathy. Bamberger-Marie disease].
Topics: Adult; Cardia; Cooperative Behavior; Diagnosis, Differential; Early Diagnosis; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastroscopy; Humans; Interdisciplinary Communication; Male; Multimodal Imaging; Neoplasm Invasiveness; Neuroendocrine Tumors; Osteoarthropathy, Secondary Hypertrophic; Paraneoplastic Syndromes; Positron-Emission Tomography; Prognosis; Risk Factors; Stomach Neoplasms; Tomography, X-Ray Computed | 2011 |
18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.
Topics: Drug Therapy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Stomach Neoplasms | 2011 |
Hepatocellular carcinoma and gastroenteropancreatic neuroendocrine tumors: potential role of other positron emission tomography radiotracers.
Topics: Animals; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radioactive Tracers; Stomach Neoplasms | 2012 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in digestive system neoplasms].
Topics: Colorectal Neoplasms; Digestive System Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2003 |
18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies.
Topics: Adult; Colorectal Neoplasms; Digestive System Neoplasms; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2003 |
Positron emission tomography in gastric and esophageal cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Stomach Neoplasms; Tomography, Emission-Computed | 2004 |
Neoplasms of the esophagus and stomach.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed; Treatment Outcome; Ultrasonography | 2004 |
[Diagnosis of gastrointestinal tract malignancies using positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG)].
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastroscopy; Humans; Lymph Nodes; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2004 |
Gastrointestinal tract malignancies and positron emission tomography: an overview.
Topics: Colorectal Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
[Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)].
Topics: Anus Neoplasms; Bile Duct Neoplasms; Colorectal Neoplasms; Digestive System Neoplasms; Endocrine Gland Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Intestine, Large; Liver Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2007 |
Solitary gastric recurrence from ovarian carcinoma: a case report and literature review.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Ovarian Neoplasms; Recurrence; Stomach Neoplasms; Tomography, Emission-Computed | 2006 |
The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategies.
Topics: Antineoplastic Agents; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Treatment Outcome | 2008 |
Quantitative techniques in 18FDG PET scanning in oncology.
Topics: Breast Neoplasms; Data Interpretation, Statistical; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Male; Medical Oncology; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Regression Analysis; Solitary Pulmonary Nodule; Stomach Neoplasms | 2008 |
18 trial(s) available for fluorodeoxyglucose f18 and Stomach Neoplasms
Article | Year |
---|---|
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Metabolic Clearance Rate; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Survival Rate; Tumor Burden | 2017 |
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Capecitabine; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Irinotecan; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Positron Emission Tomography Computed Tomography; Postoperative Care; Preoperative Care; Stomach Neoplasms | 2017 |
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardia; Endosonography; Esophagogastric Junction; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Treatment Outcome | 2018 |
Regional PET/CT after water gastric inflation for evaluating loco-regional disease of gastric cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Risk Assessment; Sensitivity and Specificity; Stomach Neoplasms; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Water | 2013 |
The Predictive and Prognostic Value of Early Metabolic Response Assessed by Positron Emission Tomography in Advanced Gastric Cancer Treated with Chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; ROC Curve; Stomach Neoplasms; Treatment Outcome; Young Adult | 2016 |
Role of gastric distention with additional water in differentiating locally advanced gastric carcinomas from physiological uptake in the stomach on 18F-fluoro-2-deoxy-D-glucose PET.
Topics: Adult; Aged; Case-Control Studies; Drinking; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Humans; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Stomach; Stomach Neoplasms; Water | 2009 |
[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorodeoxyglucose F18; Fluorouracil; Gastrectomy; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms | 2010 |
18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours.
Topics: Adult; Aged; Cell Differentiation; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Stomach Neoplasms | 2011 |
Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cisplatin; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Stomach Neoplasms; Tomography, Emission-Computed | 2003 |
What is the most appropriate scan timing for intraoperative detection of malignancy using 18F-FDG-sensitive gamma probe? Preliminary phantom and preoperative patient study.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Enhancement; Injections, Intravenous; Intraoperative Care; Middle Aged; Phantoms, Imaging; Pilot Projects; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Surgery, Computer-Assisted; Time Factors | 2004 |
The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Irritants; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms | 2004 |
Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gastrointestinal Agents; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Pentetic Acid; Radiopharmaceuticals; Stomach Neoplasms; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Tomography, Emission-Computed | 1998 |
[18F] FDG PET in gastric non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Endoscopy, Gastrointestinal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
317 other study(ies) available for fluorodeoxyglucose f18 and Stomach Neoplasms
Article | Year |
---|---|
18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC).
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Male; Neoplasm Staging; Netherlands; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms | 2021 |
Al18F-NOTA-FAPI-04 Outperforms 18F-FDG PET/CT in Identifying the Primary Lesion and Rare Metastases From Gastric Cancer.
Topics: Female; Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Quinolines; Stomach Neoplasms | 2021 |
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2021 |
Total neoadjuvant chemotherapy: a silver lining during the COVID pandemic for a patient with locally advanced diffuse distal gastric adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; COVID-19; Fluorodeoxyglucose F18; Gastrectomy; Humans; Neoadjuvant Therapy; Pandemics; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2022 |
Discordant Metabolic Response on 18F-FDG PET/CT in Synchronous Primary Gastric Lymphoma and Gastric Adenocarcinoma.
Topics: Adenocarcinoma; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2022 |
Intense 68Ga-DOTA-FAPI-04 Uptake in Diffuse Sclerotic Skeletal Metastases of Gastric Cancer.
Topics: Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Quinolines; Stomach Neoplasms | 2022 |
Predicting pathological response and overall survival in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy: the role of PET/computed tomography.
Topics: Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tumor Burden | 2022 |
HER2-Negative Schnitzler Metastasis to the Rectum Detected Using 18 F-FDG PET/CT.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectum; Stomach Neoplasms | 2022 |
Application of PET/CT in Preoperative Evaluation and Diagnosis of Gastric Cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2022 |
FDG PET/CT Imaging Findings of Renal Infarction in a Patient With Gastric Adenocarcinoma.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Infarction; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Stomach Neoplasms | 2022 |
Double Trap Escape: Omental Nodular Hyperplasia Misdiagnosed as Metastasis by 18F-FDG PET/CT and 68Ga-FAPI PET/MRI in a Patient With Gastric Adenocarcinoma.
Topics: Adenocarcinoma; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Hyperplasia; Magnetic Resonance Imaging; Male; Middle Aged; Omentum; Positron Emission Tomography Computed Tomography; Quinolines; Stomach Neoplasms | 2022 |
Combined 18 F-FDG PET/CT Radiomics and Sarcopenia Score in Predicting Relapse-Free Survival and Overall Survival in Patients With Esophagogastric Cancer.
Topics: Adenocarcinoma; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sarcopenia; Stomach Neoplasms | 2022 |
FDG PET/CT in Prostate Metastasis From Gastric Cancer.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Stomach Neoplasms | 2022 |
Preoperative prediction of the pathological stage of advanced gastric cancer by
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2022 |
Comparison of 18F-FDG and 68Ga-FAPI PET/CT in Gastric Kaposi Sarcoma.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Quinolines; Sarcoma, Kaposi; Stomach Neoplasms | 2022 |
Respiratory-gated
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2022 |
Chronic Gastritis Mimicking Malignancy on 68 Ga-FAPI-04 PET/CT.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastritis; Humans; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2023 |
Non-invasive measurement of tumor immune microenvironment and prediction of survival and chemotherapeutic benefits from
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Stomach Neoplasms; Tumor Microenvironment | 2022 |
A desmoid tumor with fluorodeoxyglucose accumulation arising from the anastomotic site of postoperative gastric cancer: a case report.
Topics: Aged; Anastomosis, Surgical; Fibromatosis, Aggressive; Fluorodeoxyglucose F18; Humans; Male; Stomach Neoplasms; Tomography, X-Ray Computed | 2022 |
Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using
Topics: Breast Neoplasms; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Pilot Projects; Receptor, ErbB-2; Stomach Neoplasms; Trastuzumab | 2023 |
Comparison of [
Topics: Aged; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Stomach Neoplasms | 2023 |
Early Detection of Gastric Intramucosal Adenocarcinoma on 68 Ga-FAPI PET/CT.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2023 |
Initial Evaluation of [
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Stomach Neoplasms | 2023 |
A Case of Rectal Dissemination of Gastric Cancer Diagnosed by Simultaneous 18 F-FDG PET/MRI.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Rectal Neoplasms; Rectum; Stomach Neoplasms | 2023 |
Predictive value of
Topics: Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tumor Burden | 2023 |
Incidental FAPI Localization in Benign Bone Lesions in a Case of Carcinoma Stomach.
Topics: Bone Diseases; Carcinoma; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2023 |
Favorable Outcome of Repeated Salvage Surgeries for Rare Metastasis to the Ligamentum Teres Hepatis and the Upper Abdominal Wall in a Stage IV Gastric Cancer Patient.
Topics: Abdominal Wall; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Peritoneal Neoplasms; Round Ligament of Liver; Stomach Neoplasms | 2023 |
Significance of CT attenuation and F-18 fluorodeoxyglucose uptake of visceral adipose tissue for predicting survival in gastric cancer patients after curative surgical resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Intra-Abdominal Fat; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate | 2020 |
Multiparametric MRI and
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Multiparametric Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2020 |
68Ga-ZHER2 PET/CT Reveals HER2-Positive Metastatic Gastric Cancer With Better Image Quality Than 18F-FDG.
Topics: Adult; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recombinant Fusion Proteins; Stomach Neoplasms | 2020 |
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience.
Topics: Aged; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Membrane Glycoproteins; Neoplasm Recurrence, Local; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Stomach Neoplasms | 2020 |
[A Case of an Elderly Male with Breast Cancer with Synchronous Triple Cancer of the Lung and Stomach].
Topics: Aged, 80 and over; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lung Neoplasms; Male; Mastectomy; Neoplasms, Multiple Primary; Stomach Neoplasms | 2019 |
[A Case of Subphrenic Lymph Node Metastasis from Gastric Cancer in Which FDG-PET/CT Was Useful for Diagnosis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2019 |
Perineural spread of gastric cancer to the sciatic nerve incidentally detected by
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sciatic Nerve; Stomach Neoplasms | 2021 |
Evaluation of the Implementation of FDG-PET/CT and Staging Laparoscopy for Gastric Cancer in The Netherlands.
Topics: Fluorodeoxyglucose F18; Humans; Laparoscopy; Neoplasm Staging; Netherlands; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2021 |
Primary malignant melanoma of the stomach: a rare entity.
Topics: Biopsy; Diagnosis, Differential; Dyspepsia; Dyspnea; Fatigue; Fluorodeoxyglucose F18; Gastrectomy; Gastroscopy; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms; Treatment Outcome | 2020 |
Evaluation of dual time-point fluorodeoxyglucose PET/computed tomography imaging in gastric cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Time Factors | 2020 |
Primary skeletal muscle lymphoma with unusual soft tissue metastases in the stomach and pancreas detected by 18F-FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Muscle, Skeletal; Pancreatic Neoplasms; Soft Tissue Neoplasms; Stomach Neoplasms | 2020 |
Primary hepatic squamous carcinoma concurrent with gastric signet ring cell carcinoma demonstrated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Carcinoma, Signet Ring Cell; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2021 |
Topics: Carcinoma; Endopeptidases; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gelatinases; Humans; Image-Guided Biopsy; Male; Membrane Proteins; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Serine Endopeptidases; Stomach Neoplasms | 2020 |
Novel 5-point 18-FDG-PET/CT visual scoring system for assessing treatment response in patients with oesophageal or gastro-oesophageal junction carcinoma.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Stomach Neoplasms | 2021 |
Incidental findings of COVID-19 in F18-FDG PET/CT from asymptomatic patients with cancer in two healthcare institutions in Bogotá, Colombia
Topics: Adult; Aged; Asymptomatic Diseases; Betacoronavirus; Carcinoma, Signet Ring Cell; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Pandemics; Pleural Effusion; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Seminoma; Stomach Neoplasms | 2020 |
18F-FDG PET/CT in a Rare Case of Poland Syndrome and Gastric Cancer.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Poland Syndrome; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2021 |
Differentiating gastric cancer and gastric lymphoma using texture analysis (TA) of positron emission tomography (PET).
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Stomach Neoplasms | 2020 |
Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Palliative Care; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms; Treatment Outcome; Tumor Burden; Tumor Microenvironment | 2021 |
Complete splenic vein tumour thrombus in primary gastric malignancy on F18-fluorodeoxyglucose positron emission tomography-computed tomography.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Vein; Stomach Neoplasms; Thrombosis; Tomography, X-Ray Computed | 2021 |
Ectopic Pancreatitis in the Gastric Antrum Mimicking Malignancy on FDG PET/CT.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Pancreatitis; Positron Emission Tomography Computed Tomography; Pyloric Antrum; Stomach Neoplasms | 2021 |
Case report: incidental findings of COVID-19 infection on positron emission tomography/computed tomography for staging of a giant gastric gastrointestinal stromal tumor.
Topics: COVID-19; COVID-19 Testing; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiography; Stomach Neoplasms | 2020 |
Changes of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Deoxyglucose; Drug Therapy, Combination; Fluorodeoxyglucose F18; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Positron-Emission Tomography; Stomach; Stomach Neoplasms; Tomography | 2021 |
Value of regular endosonography and [18F]fluorodeoxyglucose PET-CT after surgery for gastro-oesophageal junction, stomach or pancreatic cancer.
Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Endosonography; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2021 |
Increased 68Ga-FAPI-04 Uptake in Schmorl Node in a Patient With Gastric Cancer.
Topics: Aged; Biological Transport; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Nucleus Pulposus; Positron Emission Tomography Computed Tomography; Quinolines; Stomach Neoplasms | 2021 |
A pilot study on EORTC or PERCIST for the prediction of progression-free survival with nivolumab therapy in advanced or metastatic gastric cancers: A STROBE-compliant article.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nivolumab; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Progression-Free Survival; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Stomach Neoplasms | 2021 |
Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate; Young Adult | 2021 |
Bone Marrow Metastases From Gastric Adenocarcinoma on 68Ga-FAPI-04 PET/CT.
Topics: Adenocarcinoma; Adult; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Quinolines; Stomach Neoplasms | 2022 |
Glucose metabolic profiles evaluated by PET associated with molecular characteristic landscape of gastric cancer.
Topics: Fluorodeoxyglucose F18; Glucose; Glycine Plasma Membrane Transport Proteins; Humans; Metabolome; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2022 |
The role of [18F]FDG PET/CT for gastric cancer management.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2021 |
Presentation of genital tuberculosis detected on FDG PET/CT scan resembling a primary gynecologic tumor and metastases.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Genitalia; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Tuberculosis | 2021 |
Clinical implication of FDG uptake of bone marrow on PET/CT in gastric cancer patients with surgical resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Republic of Korea; Retrospective Studies; Stomach Neoplasms | 2017 |
SUVmax of 18F-FDG PET/CT correlates to expression of major chemotherapy-related tumor markers and serum tumor markers in gastric adenocarcinoma patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Pharmacological; Biomarkers, Tumor; CA-19-9 Antigen; Drug Resistance, Neoplasm; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Fluorodeoxyglucose F18; Humans; Inhibitor of Apoptosis Proteins; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Receptor, ErbB-2; Stomach Neoplasms; Survivin; Tumor Suppressor Protein p53 | 2017 |
Gastrointestinal: Multiparametric hybrid 18-FDG PET/MRI evaluation of gastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2017 |
Clinical usefulness of F-18 FDG PET in lymphoepithelioma-like gastric carcinoma.
Topics: Aged; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Gastrectomy; Herpesvirus 4, Human; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
Oligometastatic Stomach Carcinoma From Lung Squamous Cell Carcinoma Detected by 18F-FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
Misleading
Topics: Adenocarcinoma; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Emtricitabine; Fluorodeoxyglucose F18; Gastrectomy; HIV Infections; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Tenofovir; Treatment Outcome | 2018 |
Serendipitous Discovery of Isolated Gastric Metastases From Adenocarcinoma of the Lung on Staging 18F-FDG PET-CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2017 |
Uterine Metastasis From Gastric Adenocarcinoma Masquerading as Physiologic Endometrial Uptake in FDG PET/CT.
Topics: Adenocarcinoma; Adult; Biological Transport; Endometrium; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Uterine Neoplasms | 2017 |
Evolving role of FDG-PET/CT in prognostic evaluation of resectable gastric cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Stomach Neoplasms | 2017 |
Combined 18F-FDG PET/CT imaging and a gastric orthotopic xenograft model in nude mice are used to evaluate the efficacy of glycolysis-targeted therapy.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Citrates; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Injections, Intraperitoneal; Mice; Mice, Nude; Positron Emission Tomography Computed Tomography; Pyruvates; Random Allocation; Sodium Citrate; Stomach Neoplasms; Treatment Outcome; Xenograft Model Antitumor Assays | 2018 |
Effects of WD‑3 on tumor growth and the expression of integrin αvβ3 and ERK1/2 in mice bearing human gastric cancer using the 18F‑RGD PET/CT imaging system.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Integrin alphaVbeta3; MAP Kinase Signaling System; Medicine, Chinese Traditional; Mice; Paclitaxel; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2017 |
Low-grade myofibroblastic sarcoma of gastric cardia on 18F-FDG positron emission tomography/computed tomography: An extremely rare case report.
Topics: Cardia; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Myosarcoma; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2018 |
Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2018 |
Is 18F-Fluorodeoxyglucose the Tracer of Choice for Functional Imaging of Neuroendocrine Tumors Grade 3? A Case Report.
Topics: Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Intestinal Neoplasms; Ki-67 Antigen; Male; Middle Aged; Neoplasm Grading; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radioactive Tracers; Radiopharmaceuticals; Stomach Neoplasms | 2018 |
Value of Preoperative PET-CT in the Prediction of Pathological Stage of Gastric Cancer.
Topics: Aged; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2018 |
Prognostic value of diffuse splenic FDG uptake on PET/CT in patients with gastric cancer.
Topics: Aged; Area Under Curve; C-Reactive Protein; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hematocrit; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; ROC Curve; Spleen; Stomach Neoplasms; Survival Rate | 2018 |
Recurrence of Extramedullary Plasmacytomas Involving Lymph Nodes and Pancreas Revealed by 68Ga-DOTATATE and 18F-FDG PET/CT.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Lymph Nodes; Male; Neuroendocrine Tumors; Nose Neoplasms; Organometallic Compounds; Pancreatic Neoplasms; Plasmacytoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2018 |
FDG PET/CT to predict the curability of endoscopic resection for early gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Endoscopic Mucosal Resection; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Stomach Neoplasms | 2019 |
Gastric Ulcer Mimicking Malignancy on FDG PET/CT.
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Stomach Ulcer | 2019 |
Radiomic signature of
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Stomach Neoplasms; Survival Analysis; Young Adult | 2018 |
Routinely staging gastric cancer with
Topics: Adenocarcinoma; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Incidence; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Postoperative Period; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate; United Kingdom | 2019 |
Application of positron emission tomography imaging to personalize esophagogastric cancer care.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Treatment Outcome | 2019 |
Perioperative EOX treatment in operable locally advanced gastroesophageal adenocarcinoma: Prediction of tumor response by FDG -PET and histopathology.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Oxaliplatin; Perioperative Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate; Young Adult | 2019 |
Gastric schwannoma with high accumulation on fluorodeoxyglucose-positron emission tomography resected by non-exposed endoscopic wall-inversion surgery.
Topics: Female; Fluorodeoxyglucose F18; Gastroscopy; Humans; Laparoscopy; Middle Aged; Neurilemmoma; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2020 |
Adenocarcinoma of the Stomach Leading to Recurrent Regurgitation and Muscular Hypermetabolism on 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adult; Fluorodeoxyglucose F18; Humans; Laryngopharyngeal Reflux; Male; Muscles; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2019 |
Isolated Small Bowel Metastasis From Gastric Cancer Detected by 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Intestine, Small; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2019 |
Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using 18F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2019 |
Value of ¹⁸F-FDG PET/CT in the diagnosis of primary gastric cancer via stomach distension.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diatrizoate Meglumine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PET.
Topics: Afatinib; Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Mice; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines; Radiochemistry; Receptor, ErbB-2; Stomach Neoplasms; Treatment Outcome | 2013 |
18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult | 2013 |
Gastric neuroendocrine carcinoma staged and followed with (18)F-FDG PET/CT--a report of 3 cases.
Topics: Aged; Endoscopy; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Helicobacter pylori; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neuroendocrine Tumors; Radiography; Radionuclide Imaging; Stomach Neoplasms | 2013 |
Synchronous quadruple primary tumors of thyroid, breast, pancreas, and stomach: a case report.
Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Evaluation of hybrid PET/CT gastrography in gastric cancer.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Risk Factors; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
[18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer.
Topics: Aged; Biological Transport; Biomarkers; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Glucose-6-Phosphatase; Hexokinase; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Retrospective Studies; RNA, Messenger; Stomach Neoplasms; Tumor Burden | 2013 |
Investigation of incidental bowel FDG uptake.
Topics: Adenocarcinoma; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography for the evaluation of bone metastasis in patients with gastric cancer.
Topics: Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
Assessment of (18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the preoperative management of patients with gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Radiography; Stomach Neoplasms; Tomography Scanners, X-Ray Computed | 2014 |
Surgical management of patients with bowel obstructions secondary to gastric cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Intestinal Obstruction; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Recurrence, Local; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reoperation; Retrospective Studies; Risk Factors; Stomach Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Evaluating the role of fluorodeoxyglucose positron emission tomography-computed tomography in multi-disciplinary team recommendations for oesophago-gastric cancer.
Topics: Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
Glucose transporter 3 and 1 may facilitate high uptake of 18F-FDG in gastric schwannoma.
Topics: Endoscopy; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 2; Glucose Transporter Type 3; Glucose Transporter Type 4; Humans; Middle Aged; Neurilemmoma; Radionuclide Imaging; Stomach Neoplasms | 2013 |
A hepatoid adenocarcinoma of the stomach evaluated with (18)F-FDG PET/CT: intense (18)F-FDG uptake contrary to the previous report.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Statistics as Topic; Stomach; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary?
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Radioactive Tracers; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Metabolic information on staging FDG-PET-CT as a prognostic tool in the evaluation of 97 patients with gastric cancer.
Topics: Aged; Analysis of Variance; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymph Nodes; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Successful surgical treatment for pulmonary crystal-storing histiocytosis following the onset of gastric non-hodgkin lymphoma.
Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Gene Rearrangement; Histiocytes; Histiocytosis; Humans; Immunoglobulin Heavy Chains; Immunoglobulins; Immunohistochemistry; Lung; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Solitary Pulmonary Nodule; Stomach Neoplasms; Treatment Outcome | 2013 |
Follow-up after gastrectomy for cancer: an appraisal of the Italian research group for gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Italy; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach; Stomach Neoplasms; Survival Rate; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Gastroscopy; Humans; Japan; Male; Mass Screening; Middle Aged; Neoplasm Staging; Pepsinogen A; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2014 |
Inflammatory myofibroblastic tumor mimicking gastric gastrointestinal stromal tumor on 18F-FDG PET/CT.
Topics: Diagnostic Errors; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms, Muscle Tissue; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Use of an oral effervescent agent in the diagnostic of gastric carcinoma with 18F-FDG PET/CT.
Topics: Administration, Oral; Aged; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2014 |
Clinical significance of incidental findings on staging positron emission tomography for oesophagogastric malignancies.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Precancerous Conditions; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2014 |
¹⁸F-FDG PET/CT imaging for a gastrointestinal mantle cell lymphoma with multiple lymphomatous polyposis.
Topics: Adenomatous Polyps; Cell Proliferation; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Intestinal Polyposis; Ki-67 Antigen; Lymphoma, Mantle-Cell; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
PET/CT findings in a case with FDG-avid disseminated lacrimal gland MALToma with sequential development of large B-cell lymphoma and gastric MALToma.
Topics: Aged; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus Diseases; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
False-positive 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) findings of bone metastasis from esophagogastric cancer: report of two cases.
Topics: Adenocarcinoma; Aged, 80 and over; Bone Neoplasms; Carcinoma, Signet Ring Cell; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; False Positive Reactions; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Treatment Outcome | 2014 |
[Prognostic value of preoperative positron emission tomography-computed tomography in surgically resected gastric cancer].
Topics: Adult; Aged; Area Under Curve; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; ROC Curve; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
Topics: Adult; Aged; Anastomosis, Surgical; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Diagnosis of mantle-cell lymphoma relapse by 18F-FDG PET/CT after water gastric distention.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed; Water | 2014 |
Impressive response to denosumab in a patient with bone metastatic adenocarcinoma of the stomach after 2 years of zoledronic acid.
Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Middle Aged; Positron-Emission Tomography; Stomach Neoplasms; Treatment Outcome; Zoledronic Acid | 2015 |
Pulmonary tumor embolism derived from stomach cancer observation with serial 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Fluorodeoxyglucose-based positron emission tomography imaging to monitor drug responses in solid tumors.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Crizotinib; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Mice; Positron-Emission Tomography; Pyrazoles; Pyridines; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2014 |
High prognostic value of 18F-FDG PET for metastatic gastroenteropancreatic neuroendocrine tumors: a long-term evaluation.
Topics: Aged; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Probability; Prognosis; Proportional Hazards Models; Radionuclide Imaging; ROC Curve; Stomach Neoplasms; Treatment Outcome | 2014 |
Hepatoid adenocarcinoma of the stomach: dual-time-point (18)F-FDG PET/CT findings.
Topics: Adenocarcinoma; Aged; Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Mediastinal sarcoidosis mimicking lymph malignancy recurrence after anti-neoplastic therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gastrectomy; Granuloma; Humans; Hysterectomy; Lymphatic Irradiation; Lymphatic Metastasis; Mastectomy, Segmental; Mediastinal Diseases; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Stomach Neoplasms; Tissue Distribution; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intestinal Neoplasms; Ki-67 Antigen; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Can PET/CT guide the personalized treatment of patients with gastroenteropancreatic neuroendocrine neoplasms?
Topics: Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
FDG PET/CT findings of malignant fibrous histiocytoma of the stomach.
Topics: Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult | 2015 |
Combined PET/CT by 18F-FDOPA, 18F-FDA, 18F-FDG, and MRI correlation on a patient with Carney triad.
Topics: Adult; Chondroma; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
The clinical value of 18F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography for predicting regional lymph node metastasis and non-curative surgery in primary gastric carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Odds Ratio; Peritoneal Neoplasms; Positron-Emission Tomography; Regression Analysis; ROC Curve; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Impact of incidental findings on integrated 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in patients with gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Detection of synchronous gastric schwannoma on FDG PET/CT aided by discordant metabolic response.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neurilemmoma; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).
Topics: Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Stomach Neoplasms | 2015 |
Reply: Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).
Topics: Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Stomach Neoplasms | 2015 |
F-18 FDG PET/CT findings of metastatic ovarian tumors from gastrointestinal tract origin.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Tract; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Stomach; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Palliative Care; Positron-Emission Tomography; Prognosis; Receptor, ErbB-2; Retrospective Studies; ROC Curve; Stomach Neoplasms | 2016 |
Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer.
Topics: Adult; Aged; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Factors; ROC Curve; Stomach Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Metastatic Malignant Fibrous Histiocytoma in the Stomach: Imaging With 18F-FDG PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2016 |
Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by 18F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Stomach Neoplasms | 2015 |
Relationship Between 18F-FDG Uptake on PET and Recurrence Patterns After Curative Surgical Resection in Patients with Advanced Gastric Cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Young Adult | 2015 |
Evaluation of Dual Time Point Imaging 18F-FDG PET/CT in Differentiating Malignancy From Benign Gastric Disease.
Topics: Aged; China; Comparative Effectiveness Research; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Diseases; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Gastric Carcinosarcoma and 18F-FDG PET/CT.
Topics: Aged; Carcinosarcoma; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Progressing Sclerosing Mesenteritis (Mesenteric Panniculitis) Mimics Progression of Malignancy After Neoadjuvant Chemotherapy for Gastric Adenocarcinoma on Serial 18F-FDG PET/CT.
Topics: Adenocarcinoma; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Mesentery; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Panniculitis, Peritoneal; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2016 |
Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms; Survival Rate; Tissue Distribution | 2015 |
Laparoscopy, computerised tomography and fluorodeoxyglucose positron emission tomography in the management of gastric and gastro-oesophageal junction cancers.
Topics: Adult; Aged; Aged, 80 and over; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Stomach Neoplasms; Tomography, X-Ray Computed | 2016 |
Incremental diagnostic utility of gastric distension FDG PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2016 |
Incidental Detection of Urinary Leakage on FDG PET/CT Imaging for Staging of Gastric Cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Hydronephrosis; Incidental Findings; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed; Urinary Incontinence | 2016 |
Diagnostic performance of FDG PET/CT for surveillance in asymptomatic gastric cancer patients after curative surgical resection.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2016 |
Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study.
Topics: Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Stomach Neoplasms | 2016 |
Evaluation of 18F-FDG uptake for detecting lymph node metastasis of gastric cancer: a prospective pilot study for one-to-one comparison of radiation dose and pathological findings.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; ROC Curve; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Primary Tumor ¹⁸F-FDG Avidity Affects the Performance of ¹⁸F-FDG PET/CT for Detecting Gastric Cancer Recurrence.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Stomach Neoplasms; Treatment Outcome | 2016 |
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Analysis | 2016 |
Clinicopathological Parameters Influence Assessment of FDG SPECT in Gastric Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Differentiation; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, Emission-Computed, Single-Photon; Tumor Burden | 2015 |
Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric Cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Reproducibility of Results; Retrospective Studies; Stomach Neoplasms; Young Adult | 2016 |
Surgical Resection for Solitary Myocardial Metastasis of Gastric Cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart Neoplasms; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Oxonic Acid; Positron Emission Tomography Computed Tomography; Pyridines; Radiopharmaceuticals; Remission Induction; Stomach Neoplasms; Tegafur | 2016 |
Efficacy of Positron Emission Tomography/Computed Tomography in Gastric Mucosa-associated Lymphoid Tissue Lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Gastroscopy; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Stomach Neoplasms | 2016 |
The value of FDG-PET in the staging of gastric adenocarcinoma: A single institution retrospective review.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Observer Variation; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Single-Blind Method; Stomach Neoplasms; Tomography, X-Ray Computed | 2016 |
Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Stomach Neoplasms | 2016 |
Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Data Accuracy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2016 |
FLT-PET/CT diagnosis of primary and metastatic nodal lesions of gastric cancer: comparison with FDG-PET/CT.
Topics: Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2016 |
Inflammatory Fibroid Polyp of the Stomach Mimics Malignancy on 18F FDG PET/CT Imaging.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Polyps; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2016 |
Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2016 |
Prognostic value of metabolic parameters on preoperative 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in patients with stage III gastric cancer.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Liver; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2016 |
Diagnostic accuracy of 18F-FDG PET/CT for detecting synchronous advanced colorectal neoplasia in patients with gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Stomach Neoplasms | 2016 |
18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2017 |
Dual-Tracer PET/CT Using 18F-FDG and 11C-Acetate in Gastric Adenocarcinoma With Liver Metastasis.
Topics: Acetates; Adenocarcinoma; Aged; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2016 |
Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunotherapy; Lacrimal Apparatus Diseases; Lung Neoplasms; Lymph Nodes; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Multidetector Computed Tomography; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Rituximab; Soft Tissue Neoplasms; Splenic Neoplasms; Stomach Neoplasms; Treatment Outcome | 2016 |
(18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; ROC Curve; Stomach Neoplasms; Young Adult | 2016 |
Topics: Adenocarcinoma; Contrast Media; Endosonography; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
Ultrasound findings of diffuse metastasis of gastric signet-ring-cell carcinoma to the thyroid gland.
Topics: Aged; Biopsy, Fine-Needle; Carcinoma, Signet Ring Cell; Diagnosis, Differential; Endoscopy, Gastrointestinal; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms; Ultrasonography, Doppler, Color | 2017 |
PET-CT Post-Hepatic Radiation Changes in Gastroesophageal Adenocarcinoma.
Topics: Adenocarcinoma; Diagnosis, Differential; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Hepatitis; Humans; Image-Guided Biopsy; Positron Emission Tomography Computed Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy, Conformal; Stomach Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2017 |
Targeted therapy of multiple liver metastases after resected solitary gastric metastasis and primary pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; ErbB Receptors; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2016 |
Intraindividual tumor heterogeneity in NET - Further insight by C-X-C motif chemokine receptor 4-directed imaging.
Topics: Aged; Coordination Complexes; Fluorodeoxyglucose F18; Humans; Male; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2017 |
Intestinal Glycolysis Visualized by FDG PET/CT Correlates With Glucose Decrement After Gastrectomy.
Topics: Aged; Diabetes Mellitus; Female; Fluorodeoxyglucose F18; Gastrectomy; Glucose; Glycolysis; Humans; Intestinal Mucosa; Intestines; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2017 |
Predictive Role of the Number of 18F-FDG-Positive Lymph Nodes Detected by PET/CT for Pre-Treatment Evaluation of Locally Advanced Gastric Cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Gastrectomy; Gastric Bypass; Humans; Kaplan-Meier Estimate; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Preoperative Period; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Stomach Neoplasms | 2016 |
Secreted frizzled-related protein 1 overexpression in gastric cancer: Relationship with radiological findings of dual-energy spectral CT and PET-CT.
Topics: Animals; Biological Assay; Cell Line, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Tomography, X-Ray Computed; Transgenes; Up-Regulation | 2017 |
Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy.
Topics: Adenocarcinoma; Adult; Aged; Disease-Free Survival; Esophageal Neoplasms; Esophagus; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastric Mucosa; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach; Stomach Neoplasms | 2017 |
Mucosa-associated lymphoid tissue lymphoma studied with FDG-PET: a comparison with CT and endoscopic findings.
Topics: Adult; Aged; Endoscopy; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
Detecting recurrence of gastric cancer: the value of FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
F-18 fluorodeoxyglucose uptake in gastric adenoma after stomach distention by water.
Topics: Adenoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Muscle Contraction; Positron-Emission Tomography; Stomach; Stomach Neoplasms; Tomography, X-Ray Computed; Water | 2008 |
Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.
Topics: Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Observer Variation; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
Protocol considerations for positron emission tomography-computed tomography of the abdomen and pelvis.
Topics: Abdominal Neoplasms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Humans; Lymphoma; Lymphoproliferative Disorders; Pancreatic Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Sarcoma; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Proliferation; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2009 |
Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Endoscopy, Digestive System; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Pharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
F-18 FDG PET/CT in primary gastric small cell carcinoma.
Topics: Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
Pediatric gastric lymphoma: a rare entity.
Topics: Adolescent; Burkitt Lymphoma; Fluorodeoxyglucose F18; Helicobacter Infections; Helicobacter pylori; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2008 |
Abnormal FDG uptake on 18F-fluorodeoxyglucose positron emission tomography in patients with cancer diagnosis: case reports of tuberculous lymphadenitis.
Topics: Antitubercular Agents; Breast Neoplasms; Colonic Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tuberculosis, Lymph Node | 2009 |
The influence of (18)flourodeoxyglucose positron emission tomography on the management of gastroesophageal junction carcinoma.
Topics: Adenocarcinoma; Aged; Combined Modality Therapy; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2009 |
The role of PET/CT in detection of gastric cancer recurrence.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
[From retroperitoneal fibrosis to gastric linitis].
Topics: Acute Kidney Injury; Aged, 80 and over; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Linitis Plastica; Male; Pleurisy; Radiopharmaceuticals; Retroperitoneal Fibrosis; Skin Neoplasms; Stomach Neoplasms; Tomography, Emission-Computed | 2009 |
Clinical value of whole-body FDG-PET for recurrent gastric cancer: a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Whole-Body Counting | 2009 |
Significance of (18)F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography.
Topics: Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Stomach; Stomach Neoplasms | 2009 |
[Case of a sigmoid colon cancer with metachronous metastases of the stomach and the abdominal wall].
Topics: Abdominal Neoplasms; Adenocarcinoma; Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sigmoid Neoplasms; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
18F-FDG uptake and its clinical relevance in primary gastric lymphoma.
Topics: Adult; Aged; Biopsy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastric Mucosa; Gastroscopy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Stomach Ulcer; Tomography, X-Ray Computed; Young Adult | 2010 |
Intramural metastasis of esophageal carcinoma to the reconstructed gastric tube detected by FDG PET/CT.
Topics: Aged; Esophageal Neoplasms; Esophagectomy; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET-CT imaging in gastric sarcoma.
Topics: Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Sarcoma; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult | 2009 |
F-18 FDG PET/CT findings in a patient with bilateral orbital and gastric mucosa-associated lymphoid tissue lymphomas.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; Orbital Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET/CT findings in a case of gastric relapse of acute myeloblastic leukemia.
Topics: Fluorodeoxyglucose F18; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
Intra-operative use of PET probe for localization of FDG avid lesions.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Melanoma; Neoplasms; Positron-Emission Tomography; Stomach Neoplasms | 2009 |
Gastric schwannoma exhibiting increased fluorodeoxyglucose uptake.
Topics: Diagnosis, Differential; Endoscopy, Digestive System; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Laparoscopy; Middle Aged; Neurilemmoma; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2009 |
Gastric follicular lymphoma with mediastinal lymph node dissemination detected by FDG-PET.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma, Follicular; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Stomach Neoplasms | 2010 |
Cervical tuberculous lymphadenitis mimicking distant lymph node metastasis on F-18 FDG PET/CT in a patient with gastric carcinoid tumor.
Topics: Adult; Carcinoid Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed; Tuberculosis, Lymph Node | 2009 |
Primary gastric diffuse large B-cell Lymphoma (DLBCL): analyses of prognostic factors and value of pretreatment FDG-PET scan.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hemoglobins; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Rituximab; Serum Albumin; Stomach Neoplasms; Survival Analysis; Vincristine; Young Adult | 2010 |
Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Male; Middle Aged; Positron-Emission Tomography; Stomach Neoplasms | 2010 |
Isolated gastric metastasis from renal cell carcinoma 19 years after radical nephrectomy.
Topics: Aged; Biopsy; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Gastrectomy; Gastroscopy; Humans; Kidney Neoplasms; Male; Nephrectomy; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Time Factors; Treatment Outcome | 2010 |
Incidental early stage endometrial adenocarcinoma diagnosed by F-18 FDG PET-CT, which was negative on ultrasound and nonspecific on MRI.
Topics: Adenocarcinoma; Aged; Endometrial Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Subtraction Technique; Tomography, X-Ray Computed; Ultrasonography | 2010 |
High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Positron-Emission Tomography; Proportional Hazards Models; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
[Preliminary study on the validity of whole body diffusion-weighted imaging for the detection of malignant lesions].
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Whole Body Imaging; Young Adult | 2010 |
Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography.
Topics: Adult; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2010 |
Guest editorial: Neoadjuvant therapy, predictors of response, and patient outcomes.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2010 |
The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Stomach Neoplasms | 2010 |
The role of ¹⁸F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?
Topics: Adult; Aged; Decision Making; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; ROC Curve; Stomach Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
The efficacy of preoperative PET/CT for prediction of curability in surgery for locally advanced gastric carcinoma.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2010 |
Gastric adenocarcinoma? Looks similar but behaves differently!
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroendocrine Tumors; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
The role of 18F-FDG PET/CT in the evaluation of gastric cancer recurrence after curative gastrectomy.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2011 |
Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma.
Topics: Biopsy; Diagnosis, Differential; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Helicobacter pylori; Humans; Immunohistochemistry; Lymphoma, B-Cell, Marginal Zone; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2011 |
FDG PET/CT features of ovarian metastasis.
Topics: Adult; Breast Neoplasms; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2011 |
PET and PET-CT in esophageal and gastric cancer.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2011 |
F-18 FDG PET/CT detecting thyroid plasmacytoma after the successful treatment of gastric large B-cell lymphoma.
Topics: Aged, 80 and over; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Plasmacytoma; Positron-Emission Tomography; Stomach Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Molecular imaging of proliferation and glucose utilization: utility for monitoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cisplatin; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Glucose; Humans; Immunoenzyme Techniques; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms; Survival Rate | 2011 |
The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Survival Rate; Tomography, X-Ray Computed | 2011 |
Clinical implication of FDG-PET in advanced gastric cancer with signet ring cell histology.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Survival Rate; Treatment Outcome | 2011 |
Extramedullary gastric relapse of acute lymphoblastic leukemia following allogeneic stem cell transplant: staging with F-18 FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Stem Cell Transplantation; Stomach Neoplasms; Tomography, X-Ray Computed; Transplantation, Homologous | 2011 |
Detecting the recurrence of gastric cancer after curative resection: comparison of FDG PET/CT and contrast-enhanced abdominal CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2011 |
The role of 18F-FDG-PET/CT in the preoperative staging and posttherapy follow up of gastric cancer: comparison with spiral CT.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Stomach Neoplasms; Tomography, Spiral Computed | 2011 |
Gastric schwannomas show an obviously increased fluorodeoxyglucose uptake in positron emission tomography: report of two cases.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neurilemmoma; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2011 |
Primary gastric diffuse large B-cell lymphoma with orbital involvement: diagnostic usefulness of 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Biopsy; Drug Therapy; Endoscopy, Gastrointestinal; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Spectroscopy; Male; Orbit; Orbital Neoplasms; Positron-Emission Tomography; Salvage Therapy; Stomach Neoplasms; Treatment Outcome | 2011 |
A hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma detected by F-18 FDG PET/CT imaging.
Topics: Adenocarcinoma; Aged; Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2011 |
Early gastric cancer detected by 2-hour delayed FDG PET with the water gastric distention method.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Stomach; Stomach Neoplasms; Time Factors; Water | 2011 |
Gastric recurrence of a primary colon plasmacytoma: staging and evaluating response to therapy with 18F-FDG PET/CT.
Topics: Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
The use of ¹⁸F-FDG PET/CT in Cowden syndrome to differentiate multifocal gastric carcinoma from extensive benign gastric polyposis.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Hamartoma Syndrome, Multiple; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Bilateral ovarian metastases from gastric carcinoma on FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
[18F]Fluorodeoxyglucose positron emission tomography/computed tomography-positive gastric adenocarcinoma in a 12-year-old girl with Peutz-Jeghers syndrome.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastroscopy; Humans; Immunohistochemistry; Monitoring, Physiologic; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Peutz-Jeghers Syndrome; Positron-Emission Tomography; Risk Assessment; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Urologic Neoplasms | 2012 |
Predictive value of pretreatment metabolic activity measured by fluorodeoxyglucose positron emission tomography in patients with metastatic advanced gastric cancer: the maximal SUV of the stomach is a prognostic factor.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Male; Middle Aged; Models, Economic; Multimodal Imaging; Neoplasm Micrometastasis; Neoplasm Staging; Patient Care; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
[Usefulness of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in evaluation of gastric cancer stage].
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
CT, MRI, and PET findings of gastric schwannoma.
Topics: Adult; Biopsy; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Neurilemmoma; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Role of ¹⁸F-FDG PET/CT in the prediction of gastric cancer recurrence after curative surgical resection.
Topics: Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Recurrence; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Gastric cancers with microsatellite instability exhibit high fluorodeoxyglucose uptake on positron emission tomography.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Microsatellite Instability; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population.
Topics: Adenocarcinoma; Adult; Aged; Asia; Asian People; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Reference Standards; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Clinical significance of incidental colonic 18F-FDG uptake on PET/CT images in patients with gastric adenocarcinoma.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Aged, 80 and over; Colon; Colonic Neoplasms; Colonic Polyps; Colonoscopy; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tissue Distribution; Tomography, X-Ray Computed | 2012 |
How can research fields be integrated with PET imaging?
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Microsatellite Instability; Positron-Emission Tomography; Stomach Neoplasms | 2013 |
Metastatic gastric cancer from squamous cell lung carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
[A case of gastric adenocarcinoma presenting as portal hypertension].
Topics: Adenocarcinoma; Endoscopy, Gastrointestinal; Fluorodeoxyglucose F18; Humans; Hypertension, Portal; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Preclinical evaluation of a novel c-Met inhibitor in a gastric cancer xenograft model using small animal PET.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Cyclin D1; Extracellular Signal-Regulated MAP Kinases; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Mice; Mice, Nude; Phosphorylation; Positron-Emission Tomography; Proto-Oncogene Proteins c-met; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2013 |
[Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colitis; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastritis; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Proctitis; Proctocolitis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Suppressive effect of 19-nor-1α-25-dihydroxyvitamin D2 on gastric cancer cells and peritoneal metastasis model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Ergocalciferols; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred BALB C; Peritoneal Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Transplantation, Heterologous | 2012 |
Primary gastric lymphoma: utility of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for detecting relapse after treatment.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Reproducibility of Results; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult | 2013 |
Unilateral ovarian metastasis from gastric mucinous adenocarcinoma visualized on FDG PET/CT.
Topics: Adenocarcinoma, Mucinous; Adult; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastroscopy; Glucose Transporter Type 1; Glucose Transporter Type 3; Hexokinase; Humans; Ki-67 Antigen; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
SUVmax/THKmax as a biomarker for distinguishing advanced gastric carcinoma from primary gastric lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
FDG PET/CT appearance of portal vein tumor thrombus in the gastric primitive neuroectodermal tumor: uncommon primary tumor site with rare finding.
Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neuroectodermal Tumors, Primitive; Portal Vein; Positron-Emission Tomography; Stomach Neoplasms; Thrombosis; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2013 |
Simultaneous splenic and colonic metastases from gastric cancer: different FDG avidities according to the density of cancer cells imaged on FDG PET/CT.
Topics: Cell Count; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Splenic Neoplasms; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
Imaging of cutaneous recurrence of gastric cancer with F-18 FDG positron emission tomography.
Topics: Abdomen; Back; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Skin Neoplasms; Stomach Neoplasms; Tomography, Emission-Computed | 2002 |
FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Gastroscopy; Humans; Male; Middle Aged; Observer Variation; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Statistics as Topic; Stomach Neoplasms; Survival Analysis; Survival Rate | 2003 |
Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
[Neoadjuvant therapeutic principles guided by response prediction and evaluation].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Neoadjuvant Therapy; Nucleoside-Phosphate Kinase; Stomach Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sensitivity and Specificity; Stomach Neoplasms; Tomography, Emission-Computed | 2003 |
Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia.
Topics: Adenocarcinoma; Adult; Aged; Blood Glucose; Cardia; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Stomach Neoplasms; Survival Rate; Tomography, Emission-Computed | 2003 |
Peritoneal carcinomatosis: role of (18)F-FDG PET.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Mesothelial; Ovarian Neoplasms; Peritoneal Neoplasms; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2003 |
Splenic infarction mimicking gastric remnant on PET imaging.
Topics: Adenocarcinoma; Aged; Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Gastrectomy; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Splenic Infarction; Stomach Neoplasms; Tomography, Emission-Computed | 2004 |
Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Immunohistochemistry; Lymph Nodes; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Staging; Postoperative Period; Probability; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric; Stomach Neoplasms; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Chronic cholecystitis detected by FDG-PET.
Topics: Aged; Cholecystitis; Chronic Disease; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2004 |
Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET.
Topics: Algorithms; Antineoplastic Agents; Cisplatin; Fluorodeoxyglucose F18; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Statistics as Topic; Stomach Neoplasms; Treatment Outcome | 2004 |
[Glut1 expression and its relation with the absorption of 18F-FDG in stomach cancer].
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monosaccharide Transport Proteins; Radionuclide Imaging; Stomach Neoplasms | 2004 |
[Fluorodeoxyglucose-positron emission tomography in carcinoma of the esophagogastric junction].
Topics: Adult; Aged; Diagnosis, Differential; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2004 |
[Fluorodeoxiglucose F18 positron emission tomography imaging (F18FDG) for the assessment of rising levels of serum CA 19-9 in pancreatic mucinous cystadenocarcinoma. Report of one case].
Topics: Adult; CA-19-9 Antigen; Cystadenocarcinoma, Mucinous; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2004 |
[18F]Fluoro-2-deoxy-D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier.
Topics: Adult; Cadherins; DNA Mutational Analysis; Female; Fluorodeoxyglucose F18; Gastrectomy; Heterozygote; Humans; Mutation; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms | 2004 |
Intense F-18 FDG accumulation in stomach in a patient with Hodgkin lymphoma: Helicobacter pylori infection as a pitfall in oncologic diagnosis with F-18 FDG PET imaging.
Topics: Adult; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Stomach; Stomach Neoplasms | 2005 |
FDG PET imaging of signet-ring cell adenocarcinoma of the stomach.
Topics: Adult; Carcinoma, Signet Ring Cell; Feeding and Eating Disorders; Fluorodeoxyglucose F18; Humans; Male; Nausea; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2005 |
Detection of stomach peritoneal infiltration in colorectal cancer using PET-FDG.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Invasiveness; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2005 |
FDG-PET in a case of multiple bone metastases of gastric cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2005 |
Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2005 |
The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrectomy; Gastric Stump; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Whole-Body Counting | 2005 |
[Evaluation of the capacity to detect F-18-FDG-PET in stomach cancer].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms | 2005 |
Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Reproducibility of Results; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Male; Plasma Cells; Rituximab; Stomach Neoplasms; Treatment Outcome | 2005 |
[A case of focal fatty liver occurring after gastrectomy with difficulty in distinction from metastatic liver cancer ].
Topics: Aged; Diagnosis, Differential; Fatty Liver; Fluorodeoxyglucose F18; Gastrectomy; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Postoperative Complications; Stomach Neoplasms; Ultrasonography | 2005 |
Malignant lesions can mimic gastric uptake on FDG PET.
Topics: Adult; Diagnosis, Differential; Esophageal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Humans; Melanoma; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Stomach; Stomach Neoplasms | 2006 |
Scintigraphic appearance of "linitis plastica" in a patient with gastric non-Hodgkin's lymphoma on 18F-FDG imaging.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Linitis Plastica; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2006 |
F-18 FDG PET imaging in gastric neuroendocrine carcinoma.
Topics: Aged; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2006 |
[Fluorine-18 fluorodeoxyglucose-positron emission tomography imaging of carcinoma of cardia or fundus of stomach].
Topics: Adult; Aged; Aged, 80 and over; Cardia; Female; Fluorodeoxyglucose F18; Gastric Fundus; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2006 |
Diagnostic role of 18F-FDG PET in gastric MALT lymphoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Remission Induction; Retrospective Studies; Stomach Neoplasms; Time Factors | 2006 |
Early gastric cancer and early colon cancer detected simultaneously by PET cancer screening incidentally.
Topics: Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2006 |
FDG-PET in a patient with gastric MALT lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Stomach Neoplasms; Taiwan | 2006 |
Usefulness of preoperative FDG-PET for detection of gastric cancer.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neck; Neoplasm Metastasis; Positron-Emission Tomography; Preoperative Care; Stomach Neoplasms; Whole Body Imaging | 2006 |
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.
Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms; Survival Analysis | 2006 |
Laparoscopic scar: a mimicker of Sister Mary Joseph's nodule on positron emission tomography/CT.
Topics: Adenocarcinoma; Aged; Cicatrix; Contrast Media; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Laparoscopy; Male; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Enhancement; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
[A case of brain metastasis from gastric cancer involving bilateral middle cerebellar peduncles].
Topics: Adenocarcinoma; Aged; Brain Neoplasms; Cerebellum; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Stomach Neoplasms | 2006 |
Focal F-18 FDG uptake mimicking malignant gastric localizations disappearing after water ingestion on PET/CT images.
Topics: Administration, Oral; Diagnosis, Differential; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Humans; Metabolic Clearance Rate; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Stomach; Stomach Neoplasms; Subtraction Technique; Tomography, X-Ray Computed; Water | 2006 |
Gastric distension by ingesting food is useful in the evaluation of primary gastric cancer by FDG PET.
Topics: Aged; Eating; Fasting; Fluorodeoxyglucose F18; Food; Humans; Male; Middle Aged; Positron-Emission Tomography; Stomach; Stomach Neoplasms | 2007 |
[Malignant tumor with false negative 18F-FDG PET image].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Signet Ring Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Middle Aged; Omentum; Peritoneal Neoplasms; Positron-Emission Tomography; Radiographic Image Enhancement; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Immunohistochemistry; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Regression Analysis; Stomach Neoplasms | 2006 |
FDG-negative signet ring cell cancer of the stomach with FDG-positive skin metastases.
Topics: Adult; Carcinoma, Signet Ring Cell; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals; Skin Neoplasms; Stomach Neoplasms | 2007 |
Findings of fluorine-18-FDG PET in extranodal origin lymphoma--in three cases of diffuse large B cell type lymphoma.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Stomach Neoplasms | 2006 |
Gastric GIST malignancy evaluated by 18FDG-PET as compared with EUS-FNA and endoscopic biopsy.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Biopsy, Fine-Needle; Diagnosis, Differential; Endosonography; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Stromal Tumors; Gastroscopy; Humans; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Stomach Neoplasms; Tomography, Emission-Computed, Single-Photon | 2007 |
Gastric linitis plastica from metastatic breast carcinoma: FDG and FES PET appearances.
Topics: Aged; Breast Neoplasms; Carcinoma, Lobular; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Linitis Plastica; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2007 |
FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2007 |
[Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2007 |
[18F]2-fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil.
Topics: Adenocarcinoma; Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Flow Cytometry; Fluorodeoxyglucose F18; Fluorouracil; Humans; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Tumor Cells, Cultured | 2007 |
Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Stomach Neoplasms; Tissue Distribution | 2007 |
Epidermal growth factor receptor antibody plus recombinant human endostatin in treatment of hepatic metastases after remnant gastric cancer resection.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Endostatins; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Recombinant Proteins; Stomach Neoplasms | 2007 |
Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy.
Topics: Aged; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Humans; Male; Mass Screening; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms | 2007 |
Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Stomach Neoplasms; Survival Analysis; Tomography, X-Ray Computed | 2007 |
The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab.
Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Clinical Trials, Phase II as Topic; ErbB Receptors; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Remission Induction; Stomach Neoplasms; Treatment Outcome | 2007 |
Improving evaluation of primary gastric malignancies by distending the stomach with milk immediately before 18F-FDG PET scanning.
Topics: Animals; Cattle; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Milk; Positron-Emission Tomography; Radiopharmaceuticals; Stomach; Stomach Neoplasms | 2008 |
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms; Time | 2008 |
FDG avidity and PET/CT patterns in primary gastric lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tissue Distribution; Tomography, X-Ray Computed | 2008 |
F-18 FDG PET-CT findings of intraperitoneal carbon particles-induced granulomas mimicking peritoneal carcinomatosis.
Topics: Adult; Carbon; Diagnosis, Differential; Extravasation of Diagnostic and Therapeutic Materials; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Male; Middle Aged; Mitomycin; Neoplasm, Residual; Particle Size; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
[Experimental study on the effectiveness of PET tumor images for cancer diagnosis].
Topics: Adenocarcinoma; Animals; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Stomach Neoplasms; Tomography, Emission-Computed | 1994 |
Influence of chemotherapy on FDG uptake by human cancer xenografts in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Deoxyglucose; Doxorubicin; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasm Transplantation; Stomach Neoplasms; Time Factors; Tomography, Emission-Computed; Transplantation, Heterologous | 1997 |
Development of oncology protocol using fluorine-18-FDG: one center's experience.
Topics: Blood Glucose; Colonic Neoplasms; Deoxyglucose; Esophageal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphoma; Neoplasm Staging; Neoplasms; Patient Education as Topic; Practice Guidelines as Topic; Problem Solving; Quality Control; Quality of Health Care; Radiation Oncology; Radiology Information Systems; Radiopharmaceuticals; Rectal Neoplasms; Stomach Neoplasms; Tomography, Emission-Computed | 1997 |
Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Forecasting; Gastroscopy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiopharmaceuticals; Remission Induction; Stomach Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Nuclear medicine: the road to smart medicine and surgery.
Topics: Brain Diseases; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Heart Diseases; Humans; Lung Neoplasms; Nuclear Medicine; Radionuclide Imaging; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Diseases | 1998 |
Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Middle Aged; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 1998 |
Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy.
Topics: Adult; Aged; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, Emission-Computed | 2000 |
Detection of unsuspected gastric MALT-lymphoma with F-18-FDG-PET.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasms, Second Primary; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2000 |
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
Topics: Antineoplastic Agents; Benzamides; Enzyme Inhibitors; Female; Fluorodeoxyglucose F18; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Sarcoma; Stomach Neoplasms; Stromal Cells; Tomography, Emission-Computed | 2001 |
Whole-body PET with FDG for the diagnosis of recurrent gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Carcinoma, Signet Ring Cell; Databases, Factual; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Stomach Neoplasms; Survival Analysis; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose).
Topics: Adenocarcinoma; Aged; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms; Radioisotopes; Stomach Neoplasms; Tomography, Emission-Computed | 1986 |